DE122007000024I1 - Verfahren zur Herstellung von gasgef}llten Lipid-mikropartikeln und gasgef}llte Lipid-mikroartikel - Google Patents

Verfahren zur Herstellung von gasgef}llten Lipid-mikropartikeln und gasgef}llte Lipid-mikroartikel

Info

Publication number: DE122007000024I1
Authority: DE; Germany
Prior art keywords: gas; lipid microparticles; filled lipid; preparation; filled
Prior art date: 1993-06-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

DE200712000024

Other languages

English (en)

Other versions

DE122007000024I2 (de

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Lantheus Medical Imaging Inc

Original Assignee

Bristol Myers Squibb Medical Imaging Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-06-11

Filing date

1994-05-20

Publication date

2007-10-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27491252&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122007000024(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-06-11 Priority claimed from US08/076,239 external-priority patent/US5469854A/en

1993-11-30 Priority claimed from US08/160,232 external-priority patent/US5542935A/en

1994-05-20 Application filed by Bristol Myers Squibb Medical Imaging Inc filed Critical Bristol Myers Squibb Medical Imaging Inc

2007-10-04 Publication of DE122007000024I1 publication Critical patent/DE122007000024I1/de

2011-06-16 Publication of DE122007000024I2 publication Critical patent/DE122007000024I2/de

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
- A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3145—Filters incorporated in syringes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/829—Liposomes, e.g. encapsulation
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/927—Diagnostic contrast agent
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/927—Diagnostic contrast agent
- Y10S977/929—Ultrasound contrast agent

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dispersion Chemistry (AREA)
Radiology & Medical Imaging (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Acoustics & Sound (AREA)
Physics & Mathematics (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Manufacturing Of Micro-Capsules (AREA)
Ultra Sonic Daignosis Equipment (AREA)
Magnetic Resonance Imaging Apparatus (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE122007000024C 1993-06-11 1994-05-20 Verfahren zur herstellung von gasgefüllten lipid-mikropartikeln und gasgefüllte lipid-mikropartikel Active DE122007000024I2 (de)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US08/076,239 US5469854A (en)	1989-12-22	1993-06-11	Methods of preparing gas-filled liposomes
US15967493A	1993-11-30	1993-11-30
US08/160,232 US5542935A (en)	1989-12-22	1993-11-30	Therapeutic delivery systems related applications
US08/159,687 US5585112A (en)	1989-12-22	1993-11-30	Method of preparing gas and gaseous precursor-filled microspheres
PCT/US1994/005792 WO1994028780A2 (en)	1993-06-11	1994-05-20	Methods of preparing gas and gaseous precursor-filled microspheres
DE69432219T DE69432219T2 (de)	1993-06-11	1994-05-20	Verfahren zur herstellung von gasgefüllten lipid-mikropartikeln und gasgefüllte lipid-mikropartikel

Publications (2)

Publication Number	Publication Date
DE122007000024I1 true DE122007000024I1 (de)	2007-10-04
DE122007000024I2 DE122007000024I2 (de)	2011-06-16

Family

ID=27491252

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE122007000024C Active DE122007000024I2 (de)	1993-06-11	1994-05-20	Verfahren zur herstellung von gasgefüllten lipid-mikropartikeln und gasgefüllte lipid-mikropartikel
DE69432219T Expired - Lifetime DE69432219T2 (de)	1993-06-11	1994-05-20	Verfahren zur herstellung von gasgefüllten lipid-mikropartikeln und gasgefüllte lipid-mikropartikel

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE69432219T Expired - Lifetime DE69432219T2 (de)	1993-06-11	1994-05-20	Verfahren zur herstellung von gasgefüllten lipid-mikropartikeln und gasgefüllte lipid-mikropartikel

Country Status (14)

Country	Link
US (4)	US5585112A (de)
EP (2)	EP1252885A3 (de)
JP (2)	JP4274387B2 (de)
CN (1)	CN1125654C (de)
AT (1)	ATE233574T1 (de)
AU (1)	AU683900B2 (de)
CA (1)	CA2164845C (de)
DE (2)	DE122007000024I2 (de)
DK (1)	DK0712293T3 (de)
ES (1)	ES2193161T3 (de)
LU (1)	LU91325I2 (de)
NL (1)	NL300267I2 (de)
PT (1)	PT712293E (de)
WO (1)	WO1994028780A2 (de)

Families Citing this family (621)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5542935A (en)	1989-12-22	1996-08-06	Imarx Pharmaceutical Corp.	Therapeutic delivery systems related applications
US5469854A (en)	1989-12-22	1995-11-28	Imarx Pharmaceutical Corp.	Methods of preparing gas-filled liposomes
US5773024A (en) *	1989-12-22	1998-06-30	Imarx Pharmaceutical Corp.	Container with multi-phase composition for use in diagnostic and therapeutic applications
US6551576B1 (en)	1989-12-22	2003-04-22	Bristol-Myers Squibb Medical Imaging, Inc.	Container with multi-phase composition for use in diagnostic and therapeutic applications
US20020150539A1 (en)	1989-12-22	2002-10-17	Unger Evan C.	Ultrasound imaging and treatment
US5922304A (en)	1989-12-22	1999-07-13	Imarx Pharmaceutical Corp.	Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US6146657A (en)	1989-12-22	2000-11-14	Imarx Pharmaceutical Corp.	Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5656211A (en) *	1989-12-22	1997-08-12	Imarx Pharmaceutical Corp.	Apparatus and method for making gas-filled vesicles of optimal size
US6088613A (en)	1989-12-22	2000-07-11	Imarx Pharmaceutical Corp.	Method of magnetic resonance focused surgical and therapeutic ultrasound
US5733572A (en) *	1989-12-22	1998-03-31	Imarx Pharmaceutical Corp.	Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5585112A (en)	1989-12-22	1996-12-17	Imarx Pharmaceutical Corp.	Method of preparing gas and gaseous precursor-filled microspheres
US5305757A (en)	1989-12-22	1994-04-26	Unger Evan C	Gas filled liposomes and their use as ultrasonic contrast agents
US5580575A (en)	1989-12-22	1996-12-03	Imarx Pharmaceutical Corp.	Therapeutic drug delivery systems
US5776429A (en)	1989-12-22	1998-07-07	Imarx Pharmaceutical Corp.	Method of preparing gas-filled microspheres using a lyophilized lipids
US6001335A (en)	1989-12-22	1999-12-14	Imarx Pharmaceutical Corp.	Contrasting agents for ultrasonic imaging and methods for preparing the same
US6989141B2 (en) *	1990-05-18	2006-01-24	Bracco International B.V.	Ultrasound contrast agents and methods of making and using them
US20010024638A1 (en) *	1992-11-02	2001-09-27	Michel Schneider	Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
EP0732106A3 (de) *	1991-03-22	2003-04-09	Katsuro Tachibana	Mikrobläschen enthaltende Verstärker zur Ultraschalltherapie von Erkrankungen
GB9106673D0 (en) *	1991-03-28	1991-05-15	Hafslund Nycomed As	Improvements in or relating to contrast agents
US5874062A (en)	1991-04-05	1999-02-23	Imarx Pharmaceutical Corp.	Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5205290A (en)	1991-04-05	1993-04-27	Unger Evan C	Low density microspheres and their use as contrast agents for computed tomography
MX9205298A (es) *	1991-09-17	1993-05-01	Steven Carl Quay	Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
CN1068230C (zh) *	1993-01-25	2001-07-11	索纳斯药品有限公司	用作超声造影剂的相转变胶体
IL108416A (en)	1993-01-25	1998-10-30	Sonus Pharma Inc	Colloids with phase difference as contrast ultrasound agents
SE504074C2 (sv) *	1993-07-05	1996-11-04	Pharmacia Ab	Proteinberedning för subkutan, intramuskulär eller intradermal administrering
DK0711179T3 (da)	1993-07-30	2005-02-14	Imcor Pharmaceutical Co	Stabiliserede sammensætninger med mikrobobler til ultralyd
US5798091A (en)	1993-07-30	1998-08-25	Alliance Pharmaceutical Corp.	Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US6217849B1 (en) *	1993-09-29	2001-04-17	Bracco Research S.A.	Liposome suspensions as blood pool imaging contrast agents
US7083572B2 (en) *	1993-11-30	2006-08-01	Bristol-Myers Squibb Medical Imaging, Inc.	Therapeutic delivery systems
CA2154867C (en) *	1993-12-15	2007-05-29	Feng Yan	Gas mixtures useful as ultrasound contrast media
US5736121A (en)	1994-05-23	1998-04-07	Imarx Pharmaceutical Corp.	Stabilized homogenous suspensions as computed tomography contrast agents
US5792612A (en) *	1994-06-22	1998-08-11	Helsinki University Licensing, Ltd.	Use of lipids to improve the polymerse chain reaction
US5730955A (en) *	1994-08-02	1998-03-24	Molecular Biosystems, Inc.	Process for making gas-filled microspheres containing a liquid hydrophobic barrier
US5540909A (en) *	1994-09-28	1996-07-30	Alliance Pharmaceutical Corp.	Harmonic ultrasound imaging with microbubbles
US6743779B1 (en) *	1994-11-29	2004-06-01	Imarx Pharmaceutical Corp.	Methods for delivering compounds into a cell
US6383814B1 (en) *	1994-12-09	2002-05-07	Genzyme Corporation	Cationic amphiphiles for intracellular delivery of therapeutic molecules
USRE38971E1 (en)	1995-01-31	2006-02-07	Kabushiki Kaisha Toshiba	Ultrasound diagnostic apparatus and method
US5830430A (en)	1995-02-21	1998-11-03	Imarx Pharmaceutical Corp.	Cationic lipids and the use thereof
US5997898A (en) *	1995-06-06	1999-12-07	Imarx Pharmaceutical Corp.	Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US5902604A (en) *	1995-06-06	1999-05-11	Board Of Regents, The University Of Texas System	Submicron liposome suspensions obtained from preliposome lyophilizates
US6033645A (en)	1996-06-19	2000-03-07	Unger; Evan C.	Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US5804162A (en) *	1995-06-07	1998-09-08	Alliance Pharmaceutical Corp.	Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US6521211B1 (en)	1995-06-07	2003-02-18	Bristol-Myers Squibb Medical Imaging, Inc.	Methods of imaging and treatment with targeted compositions
GB9511488D0 (en) *	1995-06-07	1995-08-02	Nycomed Imaging As	Improvements in or relating to contrast agents
US6139819A (en)	1995-06-07	2000-10-31	Imarx Pharmaceutical Corp.	Targeted contrast agents for diagnostic and therapeutic use
US6231834B1 (en)	1995-06-07	2001-05-15	Imarx Pharmaceutical Corp.	Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US5897851A (en) *	1995-06-07	1999-04-27	Sonus Pharmaceuticals, Inc.	Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
US5780010A (en) *	1995-06-08	1998-07-14	Barnes-Jewish Hospital	Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
US6821506B2 (en)	1995-06-08	2004-11-23	Barnes-Jewish Hospital	Site specific binding system, imaging compositions and methods
DE19543077C2 (de) *	1995-11-13	1997-10-16	Schering Ag	Verwendung von gashaltigen Metallkomplexen als Ultraschallkontrastmittel
US5840276A (en) *	1996-01-11	1998-11-24	Apfel Enterprises, Inc.	Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis
ES2197986T3 (es) *	1996-02-19	2004-01-16	Amersham Health As	Mejoras introducidas en o relacionadas con agentes de contraste.
JP3956402B2 (ja) *	1996-03-04	2007-08-08	日本油脂株式会社	アンホテリシンｂ運搬体
EP0904113B1 (de) *	1996-03-05	2004-05-12	Acusphere, Inc.	Mikroverkapselte fluorierte gase zur anwendung als bilderzeugende mittel
US5611344A (en) *	1996-03-05	1997-03-18	Acusphere, Inc.	Microencapsulated fluorinated gases for use as imaging agents
JP2947158B2 (ja) *	1996-03-07	1999-09-13	昭和電工株式会社	ヘキサフルオロエタンの製造方法
WO1997035561A1 (en)	1996-03-28	1997-10-02	The Board Of Trustees Of The University Of Illinois	Materials and methods for making improved liposome compositions
ATE345682T1 (de)	1996-05-01	2006-12-15	Imarx Pharmaceutical Corp	In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
US5837221A (en) *	1996-07-29	1998-11-17	Acusphere, Inc.	Polymer-lipid microencapsulated gases for use as imaging agents
AU3916997A (en) *	1996-08-19	1998-03-06	Vivorx Pharmaceuticals, Inc.	Methods for the production of protein particles useful for delivery of pharmacological agents
PT929293E (pt) *	1996-08-23	2004-03-31	Sequus Pharm Inc	Lipossomas contendo um composto de cisplatina
US6414139B1 (en)	1996-09-03	2002-07-02	Imarx Therapeutics, Inc.	Silicon amphiphilic compounds and the use thereof
WO1998010798A1 (en)	1996-09-11	1998-03-19	Imarx Pharmaceutical Corp.	Improved methods for diagnostic imaging using a contrast agent and a vasodilator
US5846517A (en)	1996-09-11	1998-12-08	Imarx Pharmaceutical Corp.	Methods for diagnostic imaging using a renal contrast agent and a vasodilator
WO1998013024A2 (en) *	1996-09-27	1998-04-02	Hyal Pharmaceutical Corporation	Hyaluronic drug delivery system
ATE238073T1 (de) *	1996-10-21	2003-05-15	Amersham Health As	Verbesserungen für oder in bezug auf kontrastmitteln in ultraschallbilddarstellung
DE19648664A1 (de) *	1996-11-14	1998-05-28	Schering Ag	Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung
US20020182258A1 (en) *	1997-01-22	2002-12-05	Zycos Inc., A Delaware Corporation	Microparticles for delivery of nucleic acid
GB9701237D0 (en) *	1997-01-22	1997-03-12	Nycomed Imaging As	Improvements in or relating to contrast agents
DE19709704C2 (de)	1997-03-10	1999-11-04	Michael Georgieff	Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
US6090800A (en)	1997-05-06	2000-07-18	Imarx Pharmaceutical Corp.	Lipid soluble steroid prodrugs
US6537246B1 (en)	1997-06-18	2003-03-25	Imarx Therapeutics, Inc.	Oxygen delivery agents and uses for the same
US6120751A (en)	1997-03-21	2000-09-19	Imarx Pharmaceutical Corp.	Charged lipids and uses for the same
US6143276A (en) *	1997-03-21	2000-11-07	Imarx Pharmaceutical Corp.	Methods for delivering bioactive agents to regions of elevated temperatures
US6582392B1 (en)	1998-05-01	2003-06-24	Ekos Corporation	Ultrasound assembly for use with a catheter
US6676626B1 (en)	1998-05-01	2004-01-13	Ekos Corporation	Ultrasound assembly with increased efficacy
US7452551B1 (en)	2000-10-30	2008-11-18	Imarx Therapeutics, Inc.	Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) *	1997-05-13	2002-07-09	Bristol-Myers Squibb Medical Imaging, Inc.	Acoustically active drug delivery systems
US6217886B1 (en)	1997-07-14	2001-04-17	The Board Of Trustees Of The University Of Illinois	Materials and methods for making improved micelle compositions
JP4317270B2 (ja) *	1997-08-12	2009-08-19	ブラッコ・リサーチ・ソシエテ・アノニム	投与性組成物および磁気共鳴画像法
US6548047B1 (en) *	1997-09-15	2003-04-15	Bristol-Myers Squibb Medical Imaging, Inc.	Thermal preactivation of gaseous precursor filled compositions
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en)	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
US6565885B1 (en)	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
KR100589926B1 (ko) *	1997-09-29	2006-06-15	넥타르 테라퓨틱스	천공된 미립자 및 사용 방법
US7637948B2 (en)	1997-10-10	2009-12-29	Senorx, Inc.	Tissue marking implant
US8668737B2 (en)	1997-10-10	2014-03-11	Senorx, Inc.	Tissue marking implant
WO1999020312A1 (en) *	1997-10-21	1999-04-29	Nycomed Imaging As	Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
US6123923A (en) *	1997-12-18	2000-09-26	Imarx Pharmaceutical Corp.	Optoacoustic contrast agents and methods for their use
JPH11244386A (ja) *	1998-01-01	1999-09-14	Ge Yokogawa Medical Systems Ltd	血行阻止方法及び加温装置
US20010003580A1 (en)	1998-01-14	2001-06-14	Poh K. Hui	Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6896659B2 (en) *	1998-02-06	2005-05-24	Point Biomedical Corporation	Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
US6161034A (en) *	1999-02-02	2000-12-12	Senorx, Inc.	Methods and chemical preparations for time-limited marking of biopsy sites
RU2207808C2 (ru) *	1998-04-09	2003-07-10	Амершем Хелт АС	Применение контрастных агентов в форме частиц в диагностической визуализации для изучения физиологических параметров
US20030078227A1 (en) *	1998-07-02	2003-04-24	Greenleaf James F.	Site-directed transfection with ultrasound and cavitation nuclei
US7686763B2 (en) *	1998-09-18	2010-03-30	University Of Washington	Use of contrast agents to increase the effectiveness of high intensity focused ultrasound therapy
JP2002527410A (ja) *	1998-10-12	2002-08-27	マリンクロッド・インコーポレイテッド	新規超音波造影剤
US6725083B1 (en)	1999-02-02	2004-04-20	Senorx, Inc.	Tissue site markers for in VIVO imaging
US9820824B2 (en)	1999-02-02	2017-11-21	Senorx, Inc.	Deployment of polysaccharide markers for treating a site within a patent
US20090216118A1 (en)	2007-07-26	2009-08-27	Senorx, Inc.	Polysaccharide markers
US7651505B2 (en)	2002-06-17	2010-01-26	Senorx, Inc.	Plugged tip delivery for marker placement
US6862470B2 (en)	1999-02-02	2005-03-01	Senorx, Inc.	Cavity-filling biopsy site markers
US8361082B2 (en)	1999-02-02	2013-01-29	Senorx, Inc.	Marker delivery device with releasable plug
US8498693B2 (en)	1999-02-02	2013-07-30	Senorx, Inc.	Intracorporeal marker and marker delivery device
US7983734B2 (en)	2003-05-23	2011-07-19	Senorx, Inc.	Fibrous marker and intracorporeal delivery thereof
CA2369595C (en)	1999-04-23	2010-10-05	Alza Corporation	Conjugate having a cleavable linkage for use in a liposome
US7238368B2 (en)	1999-04-23	2007-07-03	Alza Corporation	Releasable linkage and compositions containing same
US6575991B1 (en)	1999-06-17	2003-06-10	Inrad, Inc.	Apparatus for the percutaneous marking of a lesion
US6572840B1 (en)	1999-07-28	2003-06-03	Bristol-Myers Squibb Pharma Company	Stable microbubbles comprised of a perfluoropropane encapsulated lipid moiety for use as an ultrasound contrast agent
EP1202670A4 (de) *	1999-08-13	2004-11-10	Point Biomedical Corp	Hohle mikrokugeln mit kontrollierter zerbrechlichkeit zur medizinischen verwendung
US7520856B2 (en) *	1999-09-17	2009-04-21	University Of Washington	Image guided high intensity focused ultrasound device for therapy in obstetrics and gynecology
US7510536B2 (en)	1999-09-17	2009-03-31	University Of Washington	Ultrasound guided high intensity focused ultrasound treatment of nerves
EP2289549A3 (de)	1999-10-01	2011-06-15	Immunogen, Inc.	Immunokonjugate für Krebsbehandlung
EP1229839A4 (de)	1999-10-25	2005-12-07	Therus Corp	Verwendung von fokusiertem ultraschall zur vaskulären abdichtung
US6626855B1 (en)	1999-11-26	2003-09-30	Therus Corpoation	Controlled high efficiency lesion formation using high intensity ultrasound
US7897140B2 (en) *	1999-12-23	2011-03-01	Health Research, Inc.	Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
CA2394717C (en) *	1999-12-30	2011-05-17	Judith K. Gwathmey	Iron chelator delivery system
CA2401879A1 (en) *	2000-03-06	2001-09-13	Stephan Mangin	Embolic agents visible under ultrasound
EP1267834A4 (de) *	2000-03-29	2003-08-27	Aradigm Corp	Kationische liposomen
US8404217B2 (en)	2000-05-10	2013-03-26	Novartis Ag	Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
DK1280520T4 (en)	2000-05-10	2018-06-25	Novartis Ag	Phospholipid based powders for drug delivery
EP2286843A3 (de)	2000-06-02	2011-08-03	Bracco Suisse SA	Arzneimitteln zur Zielgerichtung von Endothelzellen
US20040142475A1 (en) *	2000-06-02	2004-07-22	Barman Shikha P.	Delivery systems for bioactive agents
US6800297B2 (en)	2000-06-15	2004-10-05	Acusphere, Inc.	Porous COX-2 inhibitor matrices and methods of manufacture thereof
US6589557B2 (en) *	2000-06-15	2003-07-08	Acusphere, Inc.	Porous celecoxib matrices and methods of manufacture thereof
AU2001275489B2 (en) *	2000-06-16	2005-01-27	Sloan-Kettering Institute For Cancer Research	Liposomal encapsulation of chelated actinium-225 and uses thereof
US6599441B1 (en) *	2000-07-18	2003-07-29	Emerald Biostructures, Inc.	Crystallization solutions
US7311893B2 (en) *	2000-07-25	2007-12-25	Neurochem (International) Limited	Amyloid targeting imaging agents and uses thereof
ES2409758T3 (es)	2000-11-20	2013-06-27	Senorx, Inc.	Marcadores de sitios tisulares para formación de imagen in vivo
DE60117858T2 (de) *	2000-12-07	2006-11-30	Universiteit Utrecht Holding B.V.	Zusammensetzung zur behandlung von entzündlichen erkrankungen
US7179449B2 (en) *	2001-01-30	2007-02-20	Barnes-Jewish Hospital	Enhanced ultrasound detection with temperature-dependent contrast agents
US20030211045A1 (en) *	2001-02-05	2003-11-13	Danuta Leszcyznska	Magnetoliposome composition for targeted treatment of biological tissue and associated methods
EP1390016B2 (de) *	2001-03-30	2012-06-20	Drexel University	Echogene polymermikrokapseln und nanokapseln und verfahren zu ihrer herstellung und verwendung
US7897141B2 (en) *	2002-04-01	2011-03-01	Drexel University	Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
AU2002320348B2 (en) *	2001-07-10	2007-07-19	Sonogene, Llc	Enhancement of transfection of DNA into the liver
US20030215391A1 (en) *	2001-07-19	2003-11-20	Carlos Rabito	Fluorescent agents for real-time measurement of organ function
US7344702B2 (en) *	2004-02-13	2008-03-18	Bristol-Myers Squibb Pharma Company	Contrast agents for myocardial perfusion imaging
US20030044354A1 (en) *	2001-08-16	2003-03-06	Carpenter Alan P.	Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
CA2463724A1 (en) *	2001-10-16	2003-04-24	Structural Bioinformatics Inc.	Organosulfur inhibitors of tyrosine phosphatases
ATE520362T1 (de)	2001-12-03	2011-09-15	Ekos Corp	Katheter mit mehreren ultraschall-abstrahlenden teilen
SI1458360T1 (sl)	2001-12-19	2011-08-31	Novartis Ag	Pulmonalno dajanje aminoglikozidov
US6993394B2 (en)	2002-01-18	2006-01-31	Calfacion Corporation	System method and apparatus for localized heating of tissue
US7048756B2 (en)	2002-01-18	2006-05-23	Apasara Medical Corporation	System, method and apparatus for evaluating tissue temperature
US6850804B2 (en)	2002-01-18	2005-02-01	Calfacior Corporation	System method and apparatus for localized heating of tissue
US7407778B2 (en) *	2002-02-07	2008-08-05	Pettegrew Jay W	Compounds, compositions and methods for treating neuropsychiatric disorders
US7700074B2 (en) *	2002-02-07	2010-04-20	Pettegrew Jay W	Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US20050250700A1 (en) *	2002-03-01	2005-11-10	Sato Aaron K	KDR and VEGF/KDR binding peptides
US7666979B2 (en) *	2002-03-01	2010-02-23	Bracco International B.V.	Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
US7794693B2 (en) *	2002-03-01	2010-09-14	Bracco International B.V.	Targeting vector-phospholipid conjugates
SI2301587T1 (sl)	2002-03-01	2014-11-28	Dyax Corp.	KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi
US8623822B2 (en)	2002-03-01	2014-01-07	Bracco Suisse Sa	KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7211240B2 (en) *	2002-03-01	2007-05-01	Bracco International B.V.	Multivalent constructs for therapeutic and diagnostic applications
US20050100963A1 (en) *	2002-03-01	2005-05-12	Dyax Corporation	KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en)	2002-03-01	2007-08-28	Bracco International Bv	Multivalent constructs for therapeutic and diagnostic applications
US7985402B2 (en) *	2002-03-01	2011-07-26	Bracco Suisse Sa	Targeting vector-phospholipid conjugates
WO2003082213A2 (en) *	2002-03-28	2003-10-09	Imcor Pharmaceutical Company	Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
US7131997B2 (en)	2002-03-29	2006-11-07	Scimed Life Systems, Inc.	Tissue treatment
US7094369B2 (en)	2002-03-29	2006-08-22	Scimed Life Systems, Inc.	Processes for manufacturing polymeric microspheres
US7462366B2 (en)	2002-03-29	2008-12-09	Boston Scientific Scimed, Inc.	Drug delivery particle
US8226629B1 (en)	2002-04-01	2012-07-24	Ekos Corporation	Ultrasonic catheter power control
DE10214983A1 (de) *	2002-04-04	2004-04-08	TransMIT Gesellschaft für Technologietransfer mbH	Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
US7053134B2 (en)	2002-04-04	2006-05-30	Scimed Life Systems, Inc.	Forming a chemically cross-linked particle of a desired shape and diameter
WO2003086443A1 (en) *	2002-04-11	2003-10-23	Medimmune Vaccines, Inc.	Spray freeze dry of compositions for intranasal administration
WO2003087339A2 (en) *	2002-04-11	2003-10-23	Medimmune Vaccines, Inc.	Spray freeze dry of compositions for pulmonary administration
US8829198B2 (en) *	2007-10-31	2014-09-09	Proteotech Inc	Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
EP1371362A1 (de) *	2002-06-12	2003-12-17	Universiteit Utrecht Holding B.V.	Zusammensetzung zur Behandlung entzündlicher Erkrankungen
EP1511522B1 (de)	2002-06-12	2011-08-10	Boston Scientific Limited	Quellstoffe
US20050152962A1 (en) *	2002-06-12	2005-07-14	Metselaar Josbert M.	Composition for treatment of inflammatory disorders
CA2490692A1 (en)	2002-06-27	2004-01-08	Health Research, Inc.	Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
EP1606291A2 (de) *	2002-07-02	2005-12-21	Health Research, Inc.	Effiziente synthese von pyropheophorbid-a und seiner derivate
US7449236B2 (en)	2002-08-09	2008-11-11	Boston Scientific Scimed, Inc.	Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7842377B2 (en)	2003-08-08	2010-11-30	Boston Scientific Scimed, Inc.	Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US20040076582A1 (en) *	2002-08-30	2004-04-22	Dimatteo Kristian	Agent delivery particle
EP1393720A1 (de) *	2002-08-27	2004-03-03	Universiteit Utrecht	Vesikel enthaltend Corticosteroide zur Behandlung von Krebs
US8012454B2 (en)	2002-08-30	2011-09-06	Boston Scientific Scimed, Inc.	Embolization
WO2004027901A2 (en) *	2002-09-17	2004-04-01	Diffusion Science, Inc.	Electrochemical generation, storage and reaction of hydrogen and oxygen using gas permeable catalyst-coated hollow microspheres
US6921371B2 (en)	2002-10-14	2005-07-26	Ekos Corporation	Ultrasound radiating members for catheter
US7588825B2 (en)	2002-10-23	2009-09-15	Boston Scientific Scimed, Inc.	Embolic compositions
US7883490B2 (en)	2002-10-23	2011-02-08	Boston Scientific Scimed, Inc.	Mixing and delivery of therapeutic compositions
US20060036158A1 (en)	2003-11-17	2006-02-16	Inrad, Inc.	Self-contained, self-piercing, side-expelling marking apparatus
JP2006514954A (ja) *	2002-12-31	2006-05-18	ネクターセラピューティクス	抗体含有粒子及び組成物
AU2004217894B2 (en)	2003-03-03	2010-07-15	Bracco International B.V.	Peptides that specifically bind HGF receptor (cMet) and uses thereof
US20040258761A1 (en) *	2003-03-20	2004-12-23	Wheatley Margaret A.	Polymer-based microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
US20060198882A1 (en) *	2003-03-21	2006-09-07	Yechezkel Barenholz	Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
US20040242886A1 (en) *	2003-04-30	2004-12-02	Sandeep Gupta	Monocyclic diazodioxide based Bcl-2 protein antagonists related applications
US20040248877A1 (en) *	2003-04-30	2004-12-09	Sandeep Gupta	Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof
US7244739B2 (en) *	2003-05-14	2007-07-17	Torreypines Therapeutics, Inc.	Compounds and uses thereof in modulating amyloid beta
US7877133B2 (en)	2003-05-23	2011-01-25	Senorx, Inc.	Marker or filler forming fluid
US20060257842A1 (en) *	2003-05-29	2006-11-16	Pettegrew Jay W	Cryopreservation media and molecules
US7815894B2 (en) *	2003-05-29	2010-10-19	Jay W. Pettegrew	Compounds, compositions and methods for medical imaging of neuropsychiatric disorders
US20100331380A1 (en) *	2009-06-29	2010-12-30	Esposito Luke A	Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
US20090227647A1 (en) *	2008-03-05	2009-09-10	Thomas Lake	Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes
US8916598B2 (en)	2003-05-30	2014-12-23	Proteotech Inc	Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
US7057100B2 (en) *	2003-06-26	2006-06-06	The J.C. Robinson Seed Co.	Inbred corn line W23129
US7358226B2 (en) *	2003-08-27	2008-04-15	The Regents Of The University Of California	Ultrasonic concentration of drug delivery capsules
US7976823B2 (en)	2003-08-29	2011-07-12	Boston Scientific Scimed, Inc.	Ferromagnetic particles and methods
US20050106101A1 (en) *	2003-10-31	2005-05-19	Ajay Purohit	Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
US7901770B2 (en)	2003-11-04	2011-03-08	Boston Scientific Scimed, Inc.	Embolic compositions
US20050273002A1 (en)	2004-06-04	2005-12-08	Goosen Ryan L	Multi-mode imaging marker
US20080287560A1 (en) *	2004-12-31	2008-11-20	Loh Roland R	Polymer foams containing multi-functional layered nano-graphite
US9359481B2 (en)	2003-11-26	2016-06-07	Owens Corning Intellectual Capital, Llc	Thermoplastic foams and method of forming them using nano-graphite
US8568632B2 (en) *	2003-11-26	2013-10-29	Owens Corning Intellectual Capital, Llc	Method of forming thermoplastic foams using nano-particles to control cell morphology
US8206299B2 (en)	2003-12-16	2012-06-26	University Of Washington	Image guided high intensity focused ultrasound treatment of nerves
CN110522717A (zh)	2004-01-22	2019-12-03	迈阿密大学	局部辅酶q10制剂及其使用方法
US7201737B2 (en)	2004-01-29	2007-04-10	Ekos Corporation	Treatment of vascular occlusions using elevated temperatures
US7341569B2 (en) *	2004-01-30	2008-03-11	Ekos Corporation	Treatment of vascular occlusions using ultrasonic energy and microbubbles
WO2005090370A1 (en) *	2004-02-05	2005-09-29	The Regents Of The University Of California	Pharmacologically active agents containing esterified phosphonates and methods for use thereof
US7736671B2 (en)	2004-03-02	2010-06-15	Boston Scientific Scimed, Inc.	Embolization
US8173176B2 (en)	2004-03-30	2012-05-08	Boston Scientific Scimed, Inc.	Embolization
US7485283B2 (en) *	2004-04-28	2009-02-03	Lantheus Medical Imaging	Contrast agents for myocardial perfusion imaging
CN101198598A (zh)	2004-05-20	2008-06-11	弗尔德里克斯制药股份有限公司	2-((杂)芳基)-苯并噁唑化合物及其衍生物、组合物以及用于稳定和抑制甲状腺素转运蛋白错重叠的方法
US7311861B2 (en)	2004-06-01	2007-12-25	Boston Scientific Scimed, Inc.	Embolization
US8012457B2 (en)	2004-06-04	2011-09-06	Acusphere, Inc.	Ultrasound contrast agent dosage formulation
US7306716B2 (en) *	2004-06-16	2007-12-11	Access Business Group International Llc	Water treatment system
JP2008503490A (ja) *	2004-06-17	2008-02-07	センジェント・セラピューティクス・インコーポレイテッド	チロシンホスファターゼの三置換窒素調節物質
EP1786421A2 (de) *	2004-07-09	2007-05-23	Cengent Therapeutics, Inc.	Sauerstoff/stickstoff-heterozyklus-hemmer von tyrosinphosphatasen
US9066679B2 (en)	2004-08-31	2015-06-30	University Of Washington	Ultrasonic technique for assessing wall vibrations in stenosed blood vessels
WO2006028970A1 (en) *	2004-09-02	2006-03-16	Cengent Therapeutics, Inc.	Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
US20080009561A1 (en) *	2004-09-03	2008-01-10	Imarx Therapeutics, Inc.	Apparatus And Method To Prepare A Microsphere-Forming Composition
MX2007003044A (es) *	2004-09-16	2007-08-02	Univ Washington	Acoplador acustico que utiliza una almohada de agua independientemente con circulacion para enfriar un transductor.
NZ554545A (en)	2004-09-17	2010-10-29	Whitehead Inst Of Biomedical R	Compounds, compositions and methods of inhibiting alpha-synuclein toxicity
US20060067889A1 (en) *	2004-09-27	2006-03-30	Light Sciences Corporation	Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
DE602005008270D1 (de) *	2004-10-08	2008-08-28	Alza Corp	Verfahren zur einführung eines lipid-verknüpften teils in eine vorgeformte lipidanordnung mit mikrowellen
US8425550B2 (en)	2004-12-01	2013-04-23	Boston Scientific Scimed, Inc.	Embolic coils
US20120269886A1 (en)	2004-12-22	2012-10-25	Nitto Denko Corporation	Therapeutic agent for pulmonary fibrosis
DK1842557T3 (da)	2004-12-22	2013-12-02	Nitto Denko Corp	Lægemiddelbærer og lægemiddelbærerkit til inhibition af fibrose
CN100427142C (zh) *	2005-01-10	2008-10-22	重庆海扶(Hifu)技术有限公司	一种高强度聚焦超声治疗用助剂及其筛选方法
DK1843787T3 (da)	2005-01-28	2012-02-20	Univ Northwest	Kombination af lipider og dinitrogenoxid som hjælpestof til forøgelse af vacciners virkningsgrad
US7858183B2 (en)	2005-03-02	2010-12-28	Boston Scientific Scimed, Inc.	Particles
US7727555B2 (en)	2005-03-02	2010-06-01	Boston Scientific Scimed, Inc.	Particles
US8153435B1 (en)	2005-03-30	2012-04-10	Tracer Detection Technology Corp.	Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
WO2006130217A2 (en) *	2005-04-01	2006-12-07	The Regents Of The University Of California	Substituted phosphate esters of nucleoside phosphonates
US8222257B2 (en)	2005-04-01	2012-07-17	The Regents Of The University Of California	Phosphono-pent-2-en-1-yl nucleosides and analogs
EP1874197A4 (de) *	2005-04-12	2010-02-10	Ekos Corp	Ultraschallkatheter mit kavitationsfördernder oberfläche
EP1714642A1 (de) *	2005-04-18	2006-10-25	Bracco Research S.A.	Pharmazeutische Formulierung mit gasgefüllten Mikrokapseln zur ultraschallgesteuerten Freisetzung
US10357328B2 (en)	2005-04-20	2019-07-23	Bard Peripheral Vascular, Inc. and Bard Shannon Limited	Marking device with retractable cannula
US7963287B2 (en)	2005-04-28	2011-06-21	Boston Scientific Scimed, Inc.	Tissue-treatment methods
EP1884232A1 (de) *	2005-05-23	2008-02-06	Mebiopharm Co., Ltd.	Verfahren zur herstellung von liposomen mit darin eingeschlossenem gas
US20090221902A1 (en) *	2005-06-02	2009-09-03	Cancercure Technology As	Ultrasound Treatment Center
WO2007002109A2 (en) *	2005-06-20	2007-01-04	The Regents Of The University Of California	Multidentate pyrone-derived chelators for medicinal imaging and chelation
US9463426B2 (en)	2005-06-24	2016-10-11	Boston Scientific Scimed, Inc.	Methods and systems for coating particles
US7824659B2 (en)	2005-08-10	2010-11-02	Lantheus Medical Imaging, Inc.	Methods of making radiolabeled tracers and precursors thereof
EP1921976A2 (de)	2005-08-12	2008-05-21	University of Washington	Verfahren und gerät zur vorbereitung von organen und geweben für eine laparoskopische operation
US9011473B2 (en)	2005-09-07	2015-04-21	Ulthera, Inc.	Dissection handpiece and method for reducing the appearance of cellulite
US8518069B2 (en)	2005-09-07	2013-08-27	Cabochon Aesthetics, Inc.	Dissection handpiece and method for reducing the appearance of cellulite
US9358033B2 (en)	2005-09-07	2016-06-07	Ulthera, Inc.	Fluid-jet dissection system and method for reducing the appearance of cellulite
US10548659B2 (en)	2006-01-17	2020-02-04	Ulthera, Inc.	High pressure pre-burst for improved fluid delivery
US9486274B2 (en)	2005-09-07	2016-11-08	Ulthera, Inc.	Dissection handpiece and method for reducing the appearance of cellulite
US9187608B2 (en) *	2005-09-08	2015-11-17	Owens Corning Intellectual Capital, Llc	Polystyrene foam containing a modifier-free nanoclay and having improved fire protection performance
US8414494B2 (en)	2005-09-16	2013-04-09	University Of Washington	Thin-profile therapeutic ultrasound applicators
US8492428B2 (en) *	2005-09-20	2013-07-23	Mayo Foundation For Medical Education And Research	Small-molecule botulinum toxin inhibitors
US8016757B2 (en)	2005-09-30	2011-09-13	University Of Washington	Non-invasive temperature estimation technique for HIFU therapy monitoring using backscattered ultrasound
US8052658B2 (en)	2005-10-07	2011-11-08	Bard Peripheral Vascular, Inc.	Drug-eluting tissue marker
US8007509B2 (en)	2005-10-12	2011-08-30	Boston Scientific Scimed, Inc.	Coil assemblies, components and methods
US8167805B2 (en)	2005-10-20	2012-05-01	Kona Medical, Inc.	Systems and methods for ultrasound applicator station keeping
US8257338B2 (en) *	2006-10-27	2012-09-04	Artenga, Inc.	Medical microbubble generation
US20080200864A1 (en) *	2005-12-02	2008-08-21	Cabochon Aesthetics, Inc.	Devices and methods for selectively lysing cells
US20080195036A1 (en) *	2005-12-02	2008-08-14	Cabochon Aesthetics, Inc.	Devices and methods for selectively lysing cells
US9248317B2 (en) *	2005-12-02	2016-02-02	Ulthera, Inc.	Devices and methods for selectively lysing cells
US20080014627A1 (en) *	2005-12-02	2008-01-17	Cabochon Aesthetics, Inc.	Devices and methods for selectively lysing cells
US7885793B2 (en)	2007-05-22	2011-02-08	International Business Machines Corporation	Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
US20070140973A1 (en) *	2005-12-15	2007-06-21	Bristol-Myers Squibb Pharma Company	Contrast agents for myocardium perfusion imaging
US8152839B2 (en)	2005-12-19	2012-04-10	Boston Scientific Scimed, Inc.	Embolic coils
US8101197B2 (en)	2005-12-19	2012-01-24	Stryker Corporation	Forming coils
US7947368B2 (en)	2005-12-21	2011-05-24	Boston Scientific Scimed, Inc.	Block copolymer particles
US7501179B2 (en)	2005-12-21	2009-03-10	Boston Scientific Scimed, Inc.	Block copolymer particles
US9572886B2 (en)	2005-12-22	2017-02-21	Nitto Denko Corporation	Agent for treating myelofibrosis
US8138361B2 (en) *	2005-12-28	2012-03-20	The Trustees Of The University Of Pennsylvania	C-10 carbamates of taxanes
WO2007087418A2 (en) *	2006-01-24	2007-08-02	Imarx Therapeutics, Inc.	Composition and method for neuromuscular blockade
US20070184085A1 (en) *	2006-02-03	2007-08-09	Boston Scientific Scimed, Inc.	Ultrasound activated medical device
US20070184076A1 (en) *	2006-02-07	2007-08-09	Unger Evan C	Liquid-filled nanodroplets for anti-cancer therapy
MX2008011633A (es) *	2006-03-13	2008-12-16	Activx Biosciences Inc	Aminoquinolonas como inhibidores de gsk-3.
EA200870385A1 (ru) *	2006-03-29	2009-04-28	Фолдркс Фармасьютикалз, Инк.	Ингибирование токсичности альфа-синуклеина
WO2007127176A2 (en)	2006-04-24	2007-11-08	Ekos Corporation	Ultrasound therapy system
AU2007244705A1 (en) *	2006-04-27	2007-11-08	Barnes-Jewish Hospital	Detection and imaging of target tissue
US9220709B2 (en) *	2006-05-19	2015-12-29	Drexel University	Drug loaded contrast agents: combining diagnosis and therapy
NZ596091A (en)	2006-08-28	2012-07-27	Jolla Inst Allergy Immunolog	Antagonistic human light-specific human monoclonal antibodies
US20070080613A1 (en) *	2006-09-20	2007-04-12	Sterlite Optical Technologies Ltd	Storage and transportation device for storing and transporting optical fiber preform and precursors thereof
PT2066662E (pt)	2006-09-21	2013-02-13	Kyorin Seiyaku Kk	Inibidores de serina-hidrolase
ATE502921T1 (de)	2006-10-19	2011-04-15	Auspex Pharmaceuticals Inc	Substituierte indole
WO2008051749A2 (en)	2006-10-23	2008-05-02	C. R. Bard, Inc.	Breast marker
US8414927B2 (en)	2006-11-03	2013-04-09	Boston Scientific Scimed, Inc.	Cross-linked polymer particles
US20100137421A1 (en) *	2006-11-08	2010-06-03	Emmanuel Theodorakis	Small molecule therapeutics, synthesis of analogues and derivatives and methods of use
EP2109409B1 (de)	2006-12-12	2018-09-05	C.R.Bard, Inc.	Gewebemarker mit mehreren abbildungsmodi
EP2101670B1 (de)	2006-12-18	2013-07-31	C.R.Bard, Inc.	Biopsiemarker mit in situ erzeugten bildgebungseigenschaften
US20080146605A1 (en)	2006-12-19	2008-06-19	Auspex Pharmaceuticals, Inc.	Preparation and utility of ccr5 inhibitors
WO2008079371A1 (en) *	2006-12-22	2008-07-03	Encysive Pharmaceuticals, Inc.	Modulators of c3a receptor and methods of use thereof
US10182833B2 (en)	2007-01-08	2019-01-22	Ekos Corporation	Power parameters for ultrasonic catheter
EP2144604B1 (de)	2007-02-28	2011-09-21	Conatus Pharmaceuticals, Inc.	Verfahren zur Behandlung von chronischer viraler Hepatitis C mithilfe von RO 113-0830
WO2008106167A1 (en) *	2007-02-28	2008-09-04	Conatus Pharmaceuticals, Inc.	Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
PL2125698T3 (pl)	2007-03-15	2017-03-31	Auspex Pharmaceuticals, Inc.	Deuterowana wenlafaksyna-d9
AU2008228764B2 (en)	2007-03-22	2014-05-08	Berg Llc	Topical formulations having enhanced bioavailability
US20080242752A1 (en) *	2007-03-28	2008-10-02	Yadollah Delaviz	Polystyrene foams incorporating nanographite and HFC-134
TWI407971B (zh) *	2007-03-30	2013-09-11	Nitto Denko Corp	Cancer cells and tumor-related fibroblasts
CA2721133C (en) *	2007-04-13	2018-11-06	Somaxon Pharmaceuticals, Inc.	Low-dose doxepin formulations and methods of making and using the same
US7892776B2 (en)	2007-05-04	2011-02-22	The Regents Of The University Of California	Screening assay to identify modulators of protein kinase A
ES2471118T3 (es)	2007-06-22	2014-06-25	Ekos Corporation	Método y aparato para el tratamiento de hemorragias intracraneales
CA2692977A1 (en) *	2007-07-12	2009-01-15	Tragara Pharmaceuticals, Inc.	Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
US8389514B2 (en) *	2007-09-11	2013-03-05	Kyorin Pharmaceutical Co., Ltd.	Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
JP5373799B2 (ja)	2007-09-12	2013-12-18	杏林製薬株式会社	Ｇｓｋ−３阻害剤としてのスピロ環式アミノキノロン
US20090264421A1 (en) *	2007-10-05	2009-10-22	Bible Keith C	Methods and Compositions for Treating Cancer
US8439940B2 (en)	2010-12-22	2013-05-14	Cabochon Aesthetics, Inc.	Dissection handpiece with aspiration means for reducing the appearance of cellulite
US8426587B2 (en) *	2007-11-21	2013-04-23	Pharmaxis Ltd.	Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor
JP2011506432A (ja) *	2007-12-10	2011-03-03	エピターゲット・アーエス	非ラメラ形成脂質を含む音響感受性薬物送達粒子
US20090151241A1 (en) *	2007-12-14	2009-06-18	Dressler Lawrence V	Method for producing algae in photobioreactor
WO2009099767A2 (en)	2008-01-31	2009-08-13	C.R. Bard, Inc.	Biopsy tissue marker
KR101616139B1 (ko)	2008-02-29	2016-04-27	랜티우스 메디컬 이메징, 인크.	관류 영상화를 포함하는 용도를 위한 조영제
PT2268623E (pt)	2008-03-17	2015-09-17	Ambit Biosciences Corp	Derivados de quinazolina como moduladores de cinase raf e métodos para utilização dos mesmos
EP3015104A1 (de)	2008-04-11	2016-05-04	Berg LLC	Verfahren und verwendung zur einleitung von apoptose bei krebszellen
US8197857B2 (en) *	2008-06-06	2012-06-12	Dressler Lawrence V	Method for eliminating carbon dioxide from waste gases
GB0811856D0 (en)	2008-06-27	2008-07-30	Ucl Business Plc	Magnetic microbubbles, methods of preparing them and their uses
US20110092961A1 (en) *	2008-08-13	2011-04-21	Searete Llc	Artificial cells
CN101658533A (zh) *	2008-08-29	2010-03-03	首都医科大学宣武医院	抗肿瘤药物的干细胞递送
US9327061B2 (en)	2008-09-23	2016-05-03	Senorx, Inc.	Porous bioabsorbable implant
JP5491511B2 (ja) *	2008-10-07	2014-05-14	ブラッコ・シュイス・ソシエテ・アノニム	抗ポリマー抗体およびそれと結合するリポソームまたは微小胞を含むターゲッティング構築物
EP4215147B1 (de)	2008-12-30	2026-01-28	C. R. Bard, Inc.	Markerabgabevorrichtung zur platzierung von gewebemarkern
WO2010088450A2 (en)	2009-01-30	2010-08-05	Celladon Corporation	Methods for treating diseases associated with the modulation of serca
US20100204570A1 (en) *	2009-02-06	2010-08-12	Paul Lubock	Anchor markers
US8568793B2 (en)	2009-02-11	2013-10-29	Hope Medical Enterprises, Inc.	Sodium nitrite-containing pharmaceutical compositions
CN105601619A (zh)	2009-02-27	2016-05-25	埃姆比特生物科学公司	调控jak激酶的喹唑啉衍生物和其使用方法
EP2403860B1 (de)	2009-03-04	2015-11-04	IDENIX Pharmaceuticals, Inc.	Phosphothiophene und phosphothiazole als hcv polymerase inhibitoren
US8071591B2 (en) *	2009-03-11	2011-12-06	Kyorin Pharmaceutical Co., Ltd.	7-cycloalkylaminoquinolones as GSK-3 inhibitors
CA2754909A1 (en)	2009-03-11	2010-09-16	Ambit Biosciences Corp.	Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment
WO2010107507A1 (en) *	2009-03-20	2010-09-23	Incube Labs, Llc	Solid drug delivery apparatus, formulations and methods of use
US8461158B2 (en)	2009-03-27	2013-06-11	Pathway Therapeutics Inc.	Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
WO2010110686A1 (en)	2009-03-27	2010-09-30	Pathway Therapeutics Limited	Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
CN107261159B (zh)	2009-04-15	2021-01-12	兰休斯医疗成像公司	使用抗坏血酸稳定化放射性药物组合物
UA107660C2 (ru)	2009-04-22	2015-02-10	Аксікін Фармасьютікалз, Інк.	Антагонисты арилсульфонамидов ccr3
PE20150925A1 (es)	2009-04-22	2015-06-14	Axikin Pharmaceuticals Inc	Antagonistas de ccr3 de arilsulfonamida 2,5-disustituida
US8399456B2 (en)	2009-04-22	2013-03-19	Axikin Pharmaceuticals, Inc.	2,5-disubstituted arylsulfonamide CCR3 antagonists
SG10201402287TA (en)	2009-05-11	2014-07-30	Berg Llc	Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
DE102009031274A1 (de)	2009-06-30	2011-01-13	Justus-Liebig-Universität Giessen	Liposomen zur pulmonalen Applikation
WO2011003870A2 (en)	2009-07-06	2011-01-13	Creabilis S.A.	Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
EP2532659A1 (de)	2009-07-07	2012-12-12	Pathway Therapeutics, Inc.	Pyrimidinyl- und 1,3,5-Triazinyl-Benzimidazole und ihre Verwendung in der Krebstherapie
PT2451435T (pt)	2009-07-08	2018-01-15	Hope Medical Entpr Inc D B A Hope Pharmaceuticals	Composições farmacêuticas que contêm tiossulfato de sódio
US8404728B2 (en)	2009-07-30	2013-03-26	Mayo Foundation For Medical Education And Research	Small-molecule botulinum toxin inhibitors
CA2769652A1 (en)	2009-08-05	2011-02-10	Idenix Pharmaceuticals, Inc.	Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
US9358064B2 (en)	2009-08-07	2016-06-07	Ulthera, Inc.	Handpiece and methods for performing subcutaneous surgery
US11096708B2 (en)	2009-08-07	2021-08-24	Ulthera, Inc.	Devices and methods for performing subcutaneous surgery
MX2012001974A (es)	2009-08-19	2012-04-11	Ambit Biosciences Corp	Compuestos de biarilo y metodos de uso de los mismos.
US9532769B2 (en)	2009-09-04	2017-01-03	The University Of North Carolina At Chapel Hill	Systems, methods, and computer readable media for high frequency contrast imaging and image-guided therapeutics
EP2477550A4 (de) *	2009-09-15	2013-12-04	Univ Columbia	Systeme, verfahren und vorrichtungen für mikrobläschen
US8517962B2 (en)	2009-10-12	2013-08-27	Kona Medical, Inc.	Energetic modulation of nerves
US20110118600A1 (en)	2009-11-16	2011-05-19	Michael Gertner	External Autonomic Modulation
US11998266B2 (en)	2009-10-12	2024-06-04	Otsuka Medical Devices Co., Ltd	Intravascular energy delivery
US9119951B2 (en)	2009-10-12	2015-09-01	Kona Medical, Inc.	Energetic modulation of nerves
US20110092880A1 (en)	2009-10-12	2011-04-21	Michael Gertner	Energetic modulation of nerves
US8986231B2 (en)	2009-10-12	2015-03-24	Kona Medical, Inc.	Energetic modulation of nerves
US8986211B2 (en)	2009-10-12	2015-03-24	Kona Medical, Inc.	Energetic modulation of nerves
US8469904B2 (en)	2009-10-12	2013-06-25	Kona Medical, Inc.	Energetic modulation of nerves
US9174065B2 (en)	2009-10-12	2015-11-03	Kona Medical, Inc.	Energetic modulation of nerves
US8295912B2 (en)	2009-10-12	2012-10-23	Kona Medical, Inc.	Method and system to inhibit a function of a nerve traveling with an artery
US20160059044A1 (en)	2009-10-12	2016-03-03	Kona Medical, Inc.	Energy delivery to intraparenchymal regions of the kidney to treat hypertension
WO2011056566A2 (en)	2009-10-26	2011-05-12	Sunesis Pharmaceuticals, Inc.	Compounds and methods for treatment of cancer
WO2011056764A1 (en)	2009-11-05	2011-05-12	Ambit Biosciences Corp.	Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
US8871460B2 (en)	2009-11-09	2014-10-28	Neurogenetic Pharmaceuticals, Inc.	Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
WO2011069002A1 (en)	2009-12-02	2011-06-09	Alquest Therapeutics, Inc.	Organoselenium compounds and uses thereof
US8362068B2 (en)	2009-12-18	2013-01-29	Idenix Pharmaceuticals, Inc.	5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
US8710092B2 (en) *	2009-12-23	2014-04-29	Map Pharmaceuticals, Inc.	Substituted indolo 4,3 FG quinolines useful for treating migraine
WO2011094890A1 (en)	2010-02-02	2011-08-11	Argusina Inc.	Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
MX388479B (es)	2010-02-08	2025-03-11	Lantheus Medical Imaging Inc	Metodos y aparatos para sintetizar agentes formadores de imagen e intermedios de estos.
ES2542404T3 (es)	2010-03-02	2015-08-05	Axikin Pharmaceuticals, Inc.	Antagonistas de CCR3 de tipo arilsulfonamida enriquecidos isotópicamente
WO2011112689A2 (en)	2010-03-11	2011-09-15	Ambit Biosciences Corp.	Saltz of an indazolylpyrrolotriazine
DK2544663T3 (en) *	2010-03-12	2018-04-16	Berg Llc	INTRAVENOUS FORMULATIONS OF COENZYM Q10 (CoQ10) AND PROCEDURES FOR USING IT
AU2011227232B2 (en)	2010-03-17	2015-07-09	Axikin Pharmaceuticals Inc.	Arylsulfonamide CCR3 antagonists
US9078594B2 (en) *	2010-04-09	2015-07-14	Hitachi, Ltd.	Ultrasound diagnostic and treatment device
WO2011150201A2 (en)	2010-05-27	2011-12-01	Ambit Biosciences Corporation	Azolyl amide compounds and methods of use thereof
US9296722B2 (en)	2010-05-27	2016-03-29	Ambit Biosciences Corporation	Azolyl urea compounds and methods of use thereof
AU2011261501B2 (en)	2010-06-01	2016-01-21	Biotheryx, Inc.	Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone
CA2801001A1 (en)	2010-06-01	2011-12-08	Biotheryx, Inc.	Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
WO2011156321A1 (en)	2010-06-07	2011-12-15	Novomedix, Llc	Furanyl compounds and the use thereof
WO2012012370A1 (en)	2010-07-19	2012-01-26	Summa Health System	Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease
ITPI20100095A1 (it) *	2010-07-28	2012-01-29	Giuseppe Sabino	Un mezzo di contrasto ecografico antigene-specifico, un procedimento per la sua preparazione e suoi usi.
US20130296363A1 (en)	2010-09-01	2013-11-07	Ambit Biosciences Corporation	Quinoline and isoquinoline derivatives for use as jak modulators
EP2611794A1 (de)	2010-09-01	2013-07-10	Ambit Biosciences Corporation	4--azolylaminochinazolinderivate und verwendungsverfahren dafür
WO2012030918A1 (en)	2010-09-01	2012-03-08	Ambit Biosciences Corporation	Adenosine a3 receptor modulating compounds and methods of use thereof
MX2013002384A (es)	2010-09-01	2013-07-05	Ambit Biosciences Corp	Compuestos quinazolina y metodos para utilizarlos.
US20130317045A1 (en)	2010-09-01	2013-11-28	Ambit Biosciences Corporation	Thienopyridine and thienopyrimidine compounds and methods of use thereof
ES2581840T3 (es)	2010-09-01	2016-09-07	Ambit Biosciences Corporation	Pirazolilaminoquinazolina ópticamente activa y composiciones farmacéuticas y métodos de uso de la misma
US20130225578A1 (en)	2010-09-01	2013-08-29	Ambit Biosciences Corporation	7-cyclylquinazoline derivatives and methods of use thereof
CN103270030B (zh)	2010-09-01	2016-01-20	埃姆比特生物科学公司	吡唑基氨基喹唑啉的氢溴酸盐
US20130225615A1 (en)	2010-09-01	2013-08-29	Ambit Biosciences Corporation	2-cycloquinazoline derivatives and methods of use thereof
US20130303533A1 (en)	2010-09-01	2013-11-14	Ambit Biosciences Corporation	Azolopyridine and azolopyrimidine compounds and methods of use thereof
WO2012044641A1 (en)	2010-09-29	2012-04-05	Pathway Therapeutics Inc.	1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
US9427410B2 (en) *	2010-10-08	2016-08-30	The University Of North Carolina At Chapel Hill	Formulation of acoustically activatable particles having low vaporization energy and methods for using same
WO2012051090A1 (en)	2010-10-11	2012-04-19	Axikin Pharmaceuticals, Inc.	Salts of arylsulfonamide ccr3 antagonists
CA2819859A1 (en)	2010-12-06	2012-06-14	Follica, Inc.	Methods for treating baldness and promoting hair growth
WO2012080050A1 (en)	2010-12-14	2012-06-21	F. Hoffmann-La Roche Ag	Solid forms of a phenoxybenzenesulfonyl compound
US20120189633A1 (en)	2011-01-26	2012-07-26	Kolltan Pharmaceuticals, Inc.	Anti-kit antibodies and uses thereof
EP2670396A1 (de)	2011-01-31	2013-12-11	Celgene Corporation	Pharmazeutische zusammensetzungen aus cytidinanaloga und anwendungsverfahren dafür
TW201309690A (zh)	2011-02-10	2013-03-01	Idenix Pharmaceuticals Inc	巨環絲胺酸蛋白酶抑制劑，其醫藥組合物及其於治療ｈｃｖ感染之用途
BR112013024907A2 (pt)	2011-03-28	2016-12-20	Mei Pharma Inc	composto, composição farmacêutica, método para o tratamento, prevenção ou atenuação de um ou mais sintomas de um distúrbio, doença ou condição mediada por pi3k em um sujeito, método para modular a atividade enzimática de pi3k
WO2012135166A1 (en)	2011-03-28	2012-10-04	Pathway Therapeutics Inc.	(fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
US20140088102A1 (en)	2011-03-28	2014-03-27	Mei Pharma, Inc.	(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
US20120252721A1 (en)	2011-03-31	2012-10-04	Idenix Pharmaceuticals, Inc.	Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
KR101933732B1 (ko)	2011-04-04	2018-12-28	버그 엘엘씨	중추 신경 시스템 종양들의 치료 방법
WO2012136813A2 (en)	2011-04-07	2012-10-11	Universitetet I Oslo	Agents for medical radar diagnosis
JP5932993B2 (ja)	2011-06-17	2016-06-08	バーグエルエルシー	吸入可能な医薬組成物
US8604035B2 (en)	2011-06-23	2013-12-10	Map Pharmaceuticals, Inc.	Fluoroergoline analogs
WO2013037482A1 (en)	2011-09-15	2013-03-21	Phenex Pharmaceuticals Ag	Farnesoid x receptor agonists for cancer treatment and prevention
US8822549B2 (en) *	2011-10-13	2014-09-02	Jennifer L. Johnson	Buffered oxygen therapeutic
KR102066297B1 (ko)	2011-10-14	2020-01-14	암비트 바이오사이언시즈 코포레이션	헤테로사이클릭 화합물 및 이의 유형 3 수용체 티로신 키나아제의 조절인자로서의 용도
US9057712B1 (en)	2011-10-27	2015-06-16	Copilot Ventures Fund Iii Llc	Methods of delivery of encapsulated perfluorocarbon taggants
AU2012355982A1 (en)	2011-12-19	2014-07-10	Map Pharmaceuticals, Inc.	Novel iso-ergoline derivatives
EP2793583A4 (de)	2011-12-21	2015-08-12	Map Pharmaceuticals Inc	Neuartige neuromodulatorische verbindungen
US9611253B2 (en)	2012-02-29	2017-04-04	Ambit Biosciences Corporation	Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
TW201341367A (zh)	2012-03-16	2013-10-16	Axikin Pharmaceuticals Inc	３，５－二胺基吡唑激酶抑制劑
TR201807453T4 (tr)	2012-05-02	2018-06-21	Boehringer Ingelheim Int	Ssao'nun sübstitüe 3-haloallilamin inhibitörleri ve bunların kullanımları.
WO2013187965A1 (en)	2012-06-14	2013-12-19	Mayo Foundation For Medical Education And Research	Pyrazole derivatives as inhibitors of stat3
US9012640B2 (en)	2012-06-22	2015-04-21	Map Pharmaceuticals, Inc.	Cabergoline derivatives
KR102139393B1 (ko) *	2012-06-26	2020-07-29	지이 헬스케어 에이에스	기체 미세기포를 포함하는 조성물의 제조
NZ630363A (en)	2012-07-25	2018-09-28	Celldex Therapeutics Inc	Anti-kit antibodies and uses thereof
CN110464709A (zh)	2012-08-10	2019-11-19	德克萨斯州大学系统董事会	用于治疗中风的神经保护性脂质体组合物和方法
AU2013203000B9 (en)	2012-08-10	2017-02-02	Lantheus Medical Imaging, Inc.	Compositions, methods, and systems for the synthesis and use of imaging agents
US9074186B2 (en)	2012-08-15	2015-07-07	Boston Medical Center Corporation	Production of red blood cells and platelets from stem cells
BR112015004959A2 (pt)	2012-09-07	2017-07-04	Axikin Pharmaceuticals Inc	composto isotopicamente enriquecido, composição farmacêutica, método para tratar, prevenir ou amenizar um ou mais sintomas de uma doença, distúrbio ou condição mediada por ccr3, relacionada a eosinófilos, relacionada a basófilos, relacionada a mastócitos ou relacionada a mastócitos em um sujeito, método para tratar, prevenir ou amenizar um ou mais sintomas de uma doença inflamatória em um sujeito e método para modular a atividade de ccr3.
WO2014055647A1 (en)	2012-10-03	2014-04-10	Mei Pharma, Inc.	(sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
US9982290B2 (en)	2012-10-04	2018-05-29	The University Of North Carolina At Chapel Hill	Methods and systems for using encapsulated microbubbles to process biological samples
WO2014074765A2 (en)	2012-11-08	2014-05-15	Summa Health System	Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
EP3447046A1 (de)	2012-11-30	2019-02-27	Novomedix, LLC	Substituierte biarylsulfonamide und verwendung davon
US9169214B2 (en)	2012-12-21	2015-10-27	The Board Of Trustees Of The Leland Stanford Junior University	Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
EP2934143A4 (de)	2012-12-21	2016-06-15	Map Pharmaceuticals Inc	Neuartige methysergidderivate
EP2943188A1 (de)	2013-01-11	2015-11-18	Mayo Foundation for Medical Education and Research	Vitamine c und k zur behandlung polyzystischer erkrankungen
US9101745B2 (en)	2013-03-14	2015-08-11	Sonogene Llc	Sonochemical induction of ABCA1 expression and compositions therefor
WO2014145443A2 (en)	2013-03-15	2014-09-18	The Board Of Regents Of The University Of Texas System	Liquids rich in noble gas and methods of their preparation and use
WO2014168993A1 (en)	2013-04-08	2014-10-16	Berg Llc	Treatment of cancer using coenzyme q10 combination therapies
EP3003390B1 (de)	2013-06-06	2021-07-07	Pierre Fabre Médicament	Anti-c10orf54-antikörper und verwendungen davon
SG11201601341QA (en)	2013-08-30	2016-03-30	Ambit Biosciences Corp	Biaryl acetamide compounds and methods of use thereof
ES2825083T3 (es)	2013-09-04	2021-05-14	Berg Llc	Métodos de tratamiento contra el cáncer mediante infusión continua de coenzima Q10
NZ631142A (en)	2013-09-18	2016-03-31	Axikin Pharmaceuticals Inc	Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
WO2015042375A1 (en)	2013-09-20	2015-03-26	Idenix Pharmaceuticals, Inc.	Hepatitis c virus inhibitors
USD716450S1 (en)	2013-09-24	2014-10-28	C. R. Bard, Inc.	Tissue marker for intracorporeal site identification
USD715942S1 (en)	2013-09-24	2014-10-21	C. R. Bard, Inc.	Tissue marker for intracorporeal site identification
USD716451S1 (en)	2013-09-24	2014-10-28	C. R. Bard, Inc.	Tissue marker for intracorporeal site identification
USD715442S1 (en)	2013-09-24	2014-10-14	C. R. Bard, Inc.	Tissue marker for intracorporeal site identification
JP6870988B2 (ja)	2014-02-24	2021-05-19	セルジーンコーポレイション	神経細胞増幅及び中枢神経系障害治療のためのセレブロンの活性化因子の使用方法
GB201403775D0 (en)	2014-03-04	2014-04-16	Kymab Ltd	Antibodies, uses & methods
EP3114122A1 (de)	2014-03-05	2017-01-11	Idenix Pharmaceuticals LLC	Feste formen einer flaviviridae-virus-hemmerverbindung und salze davon
CN114940673B (zh)	2014-03-20	2025-03-18	卡佩拉医疗公司	苯并咪唑衍生物作为erbb酪氨酸激酶抑制剂用于治疗癌症
TWI705967B (zh)	2014-03-20	2020-10-01	美商卡佩拉醫療公司	苯并咪唑衍生物及其醫藥組合物及使用方法
US9968758B2 (en) *	2014-03-21	2018-05-15	Boston Scientific Scimed, Inc.	Devices and methods for treating a lung
CN106470679A (zh)	2014-05-12	2017-03-01	科内图斯医药公司	用半胱天冬酶抑制剂治疗慢性肝脏疾病并发症
CA2949998A1 (en)	2014-05-28	2015-12-03	Agenus Inc.	Anti-gitr antibodies and methods of use thereof
US9527815B2 (en)	2014-06-18	2016-12-27	Biotheryx, Inc.	Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
GB201411423D0 (en) *	2014-06-26	2014-08-13	Ge Healthcare As	Lipid sterilisation method
US9499514B2 (en)	2014-07-11	2016-11-22	Celgene Corporation	Antiproliferative compounds and methods of use thereof
WO2016025129A1 (en)	2014-08-14	2016-02-18	Alhamadsheh Mamoun M	Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
RU2723559C2 (ru)	2014-09-12	2020-06-16	Тобира Терапьютикс, Инк.	Комбинированная терапия с применением препарата ценикривирок для лечения фиброза
EP3209658A1 (de)	2014-10-24	2017-08-30	Biogen MA Inc.	Diterpenoidderivate und verfahren zur verwendung
US10925579B2 (en)	2014-11-05	2021-02-23	Otsuka Medical Devices Co., Ltd.	Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery
US10500227B2 (en) *	2014-12-03	2019-12-10	University Of Cincinnati	Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease
DK3333191T3 (da)	2014-12-11	2020-10-26	Pf Medicament	Anti-C10ORF54-antistoffer og anvendelser deraf
WO2016106221A1 (en)	2014-12-22	2016-06-30	The Rockefeller University	Anti-mertk agonistic antibodies and uses thereof
SG11201705088VA (en)	2014-12-23	2017-07-28	Axikin Pharmaceuticals Inc	3,5-diaminopyrazole kinase inhibitors
IL252705B2 (en)	2014-12-31	2023-03-01	Lantheus Medical Imaging Inc	Fat-wrapped gas microsphere preparations and related methods
CN107428745A (zh)	2015-01-20	2017-12-01	Xoc制药股份有限公司	麦角灵化合物及其用途
EP3247357A4 (de)	2015-01-20	2018-07-11	Xoc Pharmaceuticals, Inc	Isoergolinverbindungen und verwendungen davon
JP6501896B2 (ja)	2015-01-28	2019-04-17	ジェイ・エヌ・セラピューティクスＪｎＴｈｅｒａｐｅｕｔｉｃｓ	置換イミダゾ［１，２−ａ］ピリジン−２−イルアミン化合物ならびにその医薬組成物および使用方法
RU2725221C2 (ru)	2015-03-03	2020-06-30	Кимаб Лимитед	Антитела, их применение и способы применения
CN107849144B (zh)	2015-05-29	2021-09-17	艾吉纳斯公司	抗-ctla-4抗体及其使用方法
WO2016201136A1 (en)	2015-06-10	2016-12-15	Ekos Corporation	Ultrasound catheter
CN104984338A (zh) *	2015-06-23	2015-10-21	重庆医科大学	笑气作为细胞内超声空化效应增强剂的应用
KR20180015260A (ko)	2015-06-23	2018-02-12	뉴로크린 바이오사이언시즈 인코퍼레이티드	신경계 질환 또는 장애를 치료하기 위한 vmat2 억제제
WO2017040790A1 (en)	2015-09-01	2017-03-09	Agenus Inc.	Anti-pd-1 antibodies and methods of use thereof
US10065952B2 (en)	2015-10-30	2018-09-04	Neurocrine Biosciences, Inc.	Valbenazine salts and polymorphs thereof
WO2017079566A1 (en)	2015-11-05	2017-05-11	Conatus Pharmaceuticals, Inc.	Caspase inhibitors for use in the treatment of liver cancer
WO2017087576A1 (en)	2015-11-16	2017-05-26	Berg Llc	Methods of treatment of temozolomide-resistant glioma using coenzyme q10
US10112924B2 (en)	2015-12-02	2018-10-30	Astraea Therapeutics, Inc.	Piperdinyl nociceptin receptor compounds
EP4455145A3 (de)	2015-12-02	2025-03-12	Astraea Therapeutics, LLC	Piperidinyl-nociceptin-rezeptorverbindungen
LT3394057T (lt)	2015-12-23	2022-06-27	Neurocrine Biosciences, Inc.	Sintezės būdas, skirtas pagaminti (s)-(2r,3r,11br)-3-izobutil-9,10-dimetoksi-2,3,4,6,7,11b-heksahidro-1h-pirido[2,1-a]izochinolin-2-ilo 2-amino-3-metilbutanoato di(4-metilbenzensulfonatą)
WO2017117478A1 (en)	2015-12-31	2017-07-06	Conatus Pharmaceuticals Inc.	Methods of using caspase inhibitors in treatment of liver disease
EP3399981B1 (de)	2016-01-08	2023-08-02	Celgene Corporation	Feste formen von 2-(4-chlorphenyl)-n-((2-2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl)-2,2-difluoracetamid sowie deren pharmazeutische zusammensetzungen und verwendungen
WO2017120422A1 (en)	2016-01-08	2017-07-13	Celgene Corporation	Antiproliferative compounds, and their pharmaceutical compositions and uses
US10960013B2 (en)	2016-03-04	2021-03-30	East Carolina University	J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
WO2017156191A1 (en)	2016-03-08	2017-09-14	Los Gatos Pharmaceuticals, Inc.	Composite nanoparticles and uses thereof
US10407437B2 (en)	2016-03-08	2019-09-10	Los Gatos Pharmaceuticals, Inc.	Camptothecin derivatives and uses thereof
WO2017180589A1 (en)	2016-04-11	2017-10-19	Auspex Pharmaceuticals, Inc.	Deuterated ketamine derivatives
WO2017180794A1 (en)	2016-04-13	2017-10-19	Skyline Antiinfectives, Inc.	Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams
IL262647B2 (en) *	2016-05-04	2023-03-01	Lantheus Medical Imaging Inc	Methods and devices for preparing sharpness factors for ultrasound
DK3454904T3 (da)	2016-05-13	2023-02-06	Pasteur Institut	Inhibering af beta-2-nikotiniske acetylcholinreceptorer til at behandle patologi ved Alzheimers sygdom
TWI753910B (zh)	2016-05-16	2022-02-01	美商拜歐斯瑞克斯公司	吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
AU2017271588B2 (en)	2016-05-27	2022-01-20	Agenus Inc.	Anti-TIM-3 antibodies and methods of use thereof
US9789210B1 (en)	2016-07-06	2017-10-17	Lantheus Medical Imaging, Inc.	Methods for making ultrasound contrast agents
MA45602A (fr)	2016-07-08	2019-05-15	Staten Biotechnology B V	Anticorps anti-apoc3 et leurs méthodes d'utilisation
WO2018035281A1 (en)	2016-08-17	2018-02-22	North Carolina State University	Northern-southern route to synthesis of bacteriochlorins
EP3515414B1 (de)	2016-09-19	2022-11-30	MEI Pharma, Inc.	Kombinationstherapie
BR112019007369A2 (pt)	2016-10-11	2019-07-16	Agenus Inc	anticorpos anti-lag-3 e métodos de uso dos mesmos
WO2018083248A1 (en)	2016-11-03	2018-05-11	Kymab Limited	Antibodies, combinations comprising antibodies, biomarkers, uses & methods
AU2017353939B2 (en)	2016-11-07	2025-01-30	Neuracle Science Co., Ltd.	Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof
CN116987014A (zh)	2016-11-09	2023-11-03	诺沃梅迪科斯有限公司	1,1-二甲双胍的亚硝酸盐、药物组合物和使用方法
WO2018089692A1 (en)	2016-11-09	2018-05-17	Phloronol, Inc.	Eckol derivatives, methods of synthesis and uses thereof
US10836774B2 (en)	2016-11-30	2020-11-17	North Carolina State University	Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
WO2018102455A1 (en)	2016-12-01	2018-06-07	Ignyta, Inc.	Methods for the treatment of cancer
TW202345829A (zh)	2016-12-02	2023-12-01	美商紐羅克里生物科學有限公司	戊苯那嗪（valbenazine）於治療精神分裂症或情感性精神分裂症之用途
PT3551660T (pt)	2016-12-07	2023-11-30	Ludwig Inst For Cancer Res Ltd	Anticorpos anti-ctla-4 e métodos de uso dos mesmos
KR102603681B1 (ko)	2016-12-07	2023-11-17	아게누스 인코포레이티드	항체 및 이의 사용방법
KR20190108146A (ko)	2017-01-27	2019-09-23	뉴로크린 바이오사이언시즈 인코퍼레이티드	특정 vmat2 억제제의 투여 방법
NZ797281A (en)	2017-02-17	2025-10-31	Eidos Therapeutics Inc	Processes for preparing ag-10, its intermediates, and salts thereof
CA3053332A1 (en)	2017-02-17	2018-08-23	CAMRIS International, Inc.	Universal antivenom
WO2018164996A1 (en)	2017-03-06	2018-09-13	Neurocrine Biosciences, Inc.	Dosing regimen for valbenazine
CA3057841A1 (en)	2017-03-27	2018-10-04	Celgene Corporation	Methods and compositions for reduction of immunogenicity
AU2018253176B2 (en)	2017-04-13	2023-02-02	Agenus Inc.	Anti-CD137 antibodies and methods of use thereof
WO2018193427A1 (en)	2017-04-21	2018-10-25	Staten Biotechnology B.V.	Anti-apoc3 antibodies and methods of use thereof
WO2018200605A1 (en)	2017-04-26	2018-11-01	Neurocrine Biosciences, Inc.	Use of valbenazine for treating levodopa-induced dyskinesia
EP4275698A3 (de)	2017-05-01	2024-05-15	Agenus Inc.	Anti-tigit antikörper und deren verwendung
JOP20190219A1 (ar)	2017-05-09	2019-09-22	Cardix Therapeutics LLC	تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية
US10085999B1 (en)	2017-05-10	2018-10-02	Arixa Pharmaceuticals, Inc.	Beta-lactamase inhibitors and uses thereof
WO2018223065A1 (en)	2017-06-01	2018-12-06	Xoc Pharmaceuticals, Inc.	Ergoline derivatives for use in medicine
EP3645044A4 (de)	2017-06-27	2021-04-28	Neuracle Science Co., Ltd	Verwendung von anti-familie mit sequenzähnlichkeit 19, element-a5-antikörpern zur behandlung von glaukom
CN111344011B (zh)	2017-06-27	2024-01-26	纽洛可科学有限公司	抗fam19a5抗体用于治疗纤维化的用途
WO2019003165A1 (en)	2017-06-27	2019-01-03	Neuracle Science Co., Ltd.	ANTI-FAM19A5 ANTIBODIES AND USES THEREOF
KR20220031738A (ko)	2017-06-27	2022-03-11	주식회사 뉴라클사이언스	암 치료를 위한 항-fam19a5 항체의 용도
AU2018324070B2 (en)	2017-09-01	2023-05-18	East Carolina University	Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response
CN111372567B (zh)	2017-09-21	2024-03-15	纽罗克里生物科学有限公司	高剂量的缬苯那嗪制剂和与其相关的组合物、方法和试剂盒
EP3692171A4 (de)	2017-10-02	2021-06-23	Neuracle Science Co., Ltd	Verwendung einer anti-familie mit sequenzähnlichkeit 19, element-a5-antikörper zur behandlung und diagnose von gemütsstörungen
AU2018346500B2 (en)	2017-10-04	2024-10-24	The Regents Of The University Of California	Immunomodulatory oligosaccharides
KR20250070134A (ko)	2017-10-10	2025-05-20	뉴로크린 바이오사이언시즈 인코퍼레이티드	특정 vmat2 억제제의 투여 방법
AU2017435893B2 (en)	2017-10-10	2023-06-29	Neurocrine Biosciences, Inc.	Methods for the administration of certain VMAT2 inhibitors
JP7039694B2 (ja)	2017-10-31	2022-03-22	スターテン・バイオテクノロジー・ベー・フェー	抗ａｐｏｃ３抗体およびその使用方法
WO2019139871A1 (en)	2018-01-10	2019-07-18	Cura Therapeutics Llc	Pharmaceutical compositions comprising dicarboxylic acids and their therapeutic applications
WO2019139869A1 (en)	2018-01-10	2019-07-18	Cura Therapeutics Llc	Pharmaceutical compositions comprising phenylsulfonamides, and their therapeutic applications
KR102245539B1 (ko) *	2018-02-12	2021-04-29	주식회사 지앤피바이오사이언스	코어-쉘 구조의 마이크로 입자를 유효성분으로 포함하는 성장인자 유전자 발현 증가용 조성물
MY208459A (en)	2018-03-23	2025-05-10	Eidos Therapeutics Inc	Methods of treating ttr amyloidosis using ag10
EP3773752A4 (de) *	2018-03-29	2022-01-12	Case Western Reserve University	Stabilisierte nanoblasen und mikrobläschen für diagnostische und therapeutische anwendungen
EP3823986A4 (de)	2018-04-24	2022-03-23	Neuracle Science Co., Ltd	Verwendung von antikörpern gegen familie mit sequenzähnlichkeit 19, element a5 zur behandlung von neuropathischem schmerz
EP3790979A4 (de)	2018-05-08	2022-04-27	Neuracle Science Co., Ltd	Freisetzung von adeno-assoziierten viren (aav) von anti-fam19a5-antikörpern
US11970532B2 (en)	2018-05-10	2024-04-30	Neuracle Science Co., Ltd.	Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof
CA3100694A1 (en)	2018-06-14	2019-12-19	Neurocrine Biosciences, Inc.	Vmat2 inhibitor compounds, compositions, and methods relating thereto
CA3105352A1 (en)	2018-06-29	2020-01-02	Histogen, Inc.	(s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases
US20230243836A1 (en)	2018-07-20	2023-08-03	Pierre Fabre Medicament	Receptor for vista
SG11202100303QA (en)	2018-08-15	2021-02-25	Neurocrine Biosciences Inc	Methods for the administration of certain vmat2 inhibitors
FI3836920T3 (fi)	2018-08-17	2025-12-22	Eidos Therapeutics Inc	AG10-formulaatioita
KR20210070300A (ko)	2018-10-03	2021-06-14	스태튼 바이오테크놀로지 비.브이.	사람 및 시노몰구스 ApoC3에 대해 특이적인 항체 및 이의 사용 방법
US12459995B2 (en)	2018-10-16	2025-11-04	Neuracle Science Co., Ltd.	Use of anti-FAM19A5 antibodies
CN113365650A (zh)	2018-11-16	2021-09-07	新免疫技术有限公司	用il-7蛋白和免疫检查点抑制剂的组合治疗肿瘤的方法
WO2020118042A1 (en)	2018-12-05	2020-06-11	Jacobs Wagner Christine	Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of lyme disease-related pathologies
KR20200071198A (ko)	2018-12-10	2020-06-19	네오이뮨텍, 인코퍼레이티드	Nrf2 발현 조절 기반 T 세포 항암면역치료법
US12391705B2 (en)	2018-12-19	2025-08-19	Shy Therapeutics, Llc	Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
KR20240000655A (ko)	2018-12-27	2024-01-02	주식회사 뉴라클사이언스	죽상경화증을 치료하기 위한 항-fam19a5 항체의 사용
EP3906260A4 (de)	2019-01-02	2022-08-31	Neuracle Science Co., Ltd	Anti-familie mit sequenzähnlichkeit 19, element a5-antikörper und verfahren zur verwendung davon
CN109602450B (zh) *	2019-01-29	2021-04-30	北京大学第三医院（北京大学第三临床医学院）	一种超声腔内探头隔离及导声一体化装置
TWI839461B (zh)	2019-02-06	2024-04-21	美商戴斯阿爾法股份有限公司	Il-17a調節物及其用途
CN113874081A (zh)	2019-02-26	2021-12-31	茵思博纳公司	高-亲和力抗-mertk抗体及其用途
IL286149B2 (en)	2019-03-07	2025-02-01	Histogen Inc	CASPASE INHIBITORS AND METHODS OF USING THEM
WO2020236818A1 (en)	2019-05-20	2020-11-26	Nirvana Sciences Inc.	Narrow emission dyes, compositions comprising same, and methods for making and using same
JP2022532925A (ja)	2019-05-20	2022-07-20	ニルバナサイエンシーズインク．	発光波長の範囲が狭い発光染料、それを含む組成物及びそれを製造及び使用する方法
CA3146159A1 (en)	2019-07-11	2021-01-14	Cura Therapeutics, Llc	Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
AU2020311404A1 (en)	2019-07-11	2022-03-03	Cura Therapeutics, Llc	Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases
US10940141B1 (en)	2019-08-23	2021-03-09	Neurocrine Biosciences, Inc.	Methods for the administration of certain VMAT2 inhibitors
CN114585644A (zh)	2019-08-30	2022-06-03	艾吉纳斯公司	抗cd96抗体及其使用方法
CA3154608A1 (en)	2019-09-16	2021-03-25	Dice Alpha, Inc.	Il-17a modulators and uses thereof
KR20220150274A (ko)	2020-01-13	2022-11-10	네오이뮨텍, 인코퍼레이티드	Il-7 단백질과 이중특이적 항체의 조합물을 사용한 종양의 치료 방법
EP4093751A1 (de)	2020-01-22	2022-11-30	Outpace Bio, Inc.	Chimäre polypeptide
WO2021158783A1 (en)	2020-02-05	2021-08-12	Washington University	Method of treating a solid tumor with a combination of an il-7 protein and car-bearing immune cells
WO2021242970A1 (en)	2020-05-29	2021-12-02	Boulder Bioscience Llc	Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane
US20230227466A1 (en)	2020-06-18	2023-07-20	Shy Therapeutics, Llc	Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
CN111729093B (zh) *	2020-06-29	2022-05-24	南京超维景生物科技有限公司	一种造影剂成膜剂组合物、造影剂成膜脂液、造影剂及其制备方法
WO2022006228A1 (en)	2020-06-30	2022-01-06	Prosetta Biosciences, Inc.	Isoquinoline derivatives, methods of synthesis and uses thereof
CN111617267A (zh) *	2020-07-07	2020-09-04	南京大学	一种包载全氟化碳的纳米级超声造影剂
WO2022061348A1 (en)	2020-09-16	2022-03-24	Biotheryx, Inc.	Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
WO2022087335A1 (en)	2020-10-23	2022-04-28	Biotheryx, Inc.	Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
WO2022094475A1 (en)	2020-11-02	2022-05-05	Neoimmunetech, Inc.	Use of interleukin-7 for the treatment of coronavirus
CA3195594A1 (en)	2020-11-05	2022-05-12	Byung Ha Lee	Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine
WO2022132603A1 (en)	2020-12-14	2022-06-23	Biotheryx, Inc.	Pde4 degraders, pharmaceutical compositions, and therapeutic applications
US20220233762A1 (en) *	2021-01-26	2022-07-28	Agitated Solutions Inc.	Syringe-based microbubble generator with an aerator
US20240124483A1 (en)	2021-01-27	2024-04-18	Shy Therapeutics, Llc	Methods for the Treatment of Fibrotic Disease
US20240309015A1 (en)	2021-01-27	2024-09-19	Shy Therapeutics, Llc	Methods for the Treatment of Fibrotic Disease
MX2023010545A (es)	2021-03-10	2023-11-24	Dice Molecules Sv Inc	Inhibidores de integrinas alfa v beta 6 y alfa v beta 1 y usos de los mismos.
EP4326721A1 (de)	2021-04-22	2024-02-28	Protego Biopharma, Inc.	Spirocyclische imidazolidinone und imidazolidindione zur behandlung von leichtkettiger amyloidose
WO2022251533A1 (en)	2021-05-27	2022-12-01	Protego Biopharma, Inc.	Heteroaryl diamide ire1/xbp1s activators
WO2022251644A1 (en)	2021-05-28	2022-12-01	Lyell Immunopharma, Inc.	Nr4a3-deficient immune cells and uses thereof
EP4347826A1 (de)	2021-06-02	2024-04-10	Lyell Immunopharma, Inc.	Nr4a3-defiziente immunzellen und verwendungen davon
EP4355776A1 (de)	2021-06-14	2024-04-24	Argenx BV	Anti-il-9-antikörper und verfahren zur verwendung davon
WO2022266249A1 (en)	2021-06-16	2022-12-22	Biotheryx, Inc.	Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
WO2022266248A1 (en)	2021-06-16	2022-12-22	Biotheryx, Inc.	Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
WO2023055045A1 (ko)	2021-09-29	2023-04-06	주식회사 엔바이오스	코일드 코일 융합 단백질
CA3236150A1 (en)	2021-10-22	2023-04-27	Prosetta Biosciences, Inc.	Novel host-targeted pan-respiratory antiviral small molecule therapeutics
KR20240115979A (ko)	2021-11-08	2024-07-26	프로젠토스 테라퓨틱스, 인크.	혈소판-유래 성장 인자 수용체(pdgfr) 알파 억제제 및 이의 용도
KR20240130705A (ko)	2021-12-30	2024-08-29	네오이뮨텍, 인코퍼레이티드	Il-7 단백질 및 vegf 길항제의 조합으로 종양을 치료하는 방법
US11932665B2 (en)	2022-01-03	2024-03-19	Lilac Therapeutics, Inc.	Cyclic thiol prodrugs
EP4433040A4 (de)	2022-01-03	2025-11-12	Lilac Therapeutics Inc	Acyclische thiol-prodrugs
KR20230125129A (ko)	2022-02-17	2023-08-29	주식회사 노벨티노빌리티	항체-약물 접합체
CA3253352A1 (en)	2022-03-02	2023-09-07	Mitopower, Inc.	NEW PROMEDICINAL PRODUCTS DERIVED FROM NICOTINIC ACID AND RIBOSE
CA3254863A1 (en)	2022-03-30	2023-10-05	Biomarin Pharmaceutical Inc.	DYSTROPHIN EXON-SKIPPING OLIGONUCLEOTIDES
GB2619907A (en)	2022-04-01	2023-12-27	Kanna Health Ltd	Novel crystalline salt forms of mesembrine
WO2023201282A1 (en)	2022-04-14	2023-10-19	Bristol-Myers Squibb Company	Novel gspt1 compounds and methods of use of the novel compounds
US20230416741A1 (en)	2022-05-05	2023-12-28	Biomarin Pharmaceutical Inc.	Method of treating duchenne muscular dystrophy
CN120092003A (zh)	2022-05-10	2025-06-03	拜欧斯瑞克斯公司	Cdk蛋白降解剂、药物组合物和治疗应用
CA3253951A1 (en)	2022-05-19	2023-11-23	Lyell Immunopharma, Inc.	NR4A3 Targeted Polynucleotides and Their Uses
KR20250099113A (ko)	2022-09-09	2025-07-01	이노보 테라퓨틱스 인코포레이티드	CK1α 및 DUAL CK1α/GSPT1 분해 화합물
EP4593826A1 (de)	2022-09-30	2025-08-06	Boulder Bioscience LLC	Zusammensetzungen mit 3,3'-diindolylmethan zur behandlung von nichthämorrhagischen verletzungen des geschlossenen kopfes
US20240209100A1 (en)	2022-10-21	2024-06-27	Diagonal Therapeutics Inc.	Heteromeric agonistic antibodies to il-18 receptor
WO2024092037A1 (en)	2022-10-26	2024-05-02	Protego Biopharma, Inc.	Spirocycle containing pyridone compounds
WO2024092040A1 (en)	2022-10-26	2024-05-02	Protego Biopharma, Inc.	Spirocycle containing bicyclic heteroaryl compounds
US20240174673A1 (en)	2022-10-26	2024-05-30	Protego Biopharma, Inc.	Spirocycle Containing Pyridine Compounds
EP4615485A1 (de)	2022-11-07	2025-09-17	NeoImmuneTech, Inc.	Verfahren zur behandlung eines tumors mit einem unmethylierten mgmt-promotor
WO2024118810A1 (en)	2022-11-30	2024-06-06	Protego Biopharma, Inc.	Cyclic pyrazole diamide ire1/xbp1s activators
EP4626864A1 (de)	2022-11-30	2025-10-08	Protego Biopharma, Inc.	Lineare heteroaryldiamid-ire1/xbp1s-aktivatoren
WO2024194685A2 (en)	2023-03-17	2024-09-26	Oxitope Pharma B.V.	Anti-phosphocholine antibodies and methods of use thereof
WO2024194686A2 (en)	2023-03-17	2024-09-26	Oxitope Pharma B.V.	Anti-phosphocholine antibodies and methods of use thereof
CN121057752A (zh)	2023-04-07	2025-12-02	达科纳治疗有限公司	铰链经修饰的双特异性抗体
WO2024211796A1 (en)	2023-04-07	2024-10-10	Diagonal Therapeutics Inc.	Bispecific agonistic antibodies to activin a receptor like type 1 (alk1)
WO2024226471A2 (en)	2023-04-24	2024-10-31	Biomarin Pharmaceutical Inc.	Compositions and methods for treating stxbp1 disorders
TW202448485A (zh)	2023-05-05	2024-12-16	美商拜奧馬林製藥公司	肌萎縮蛋白外顯子跳躍寡核苷酸
AU2024269869A1 (en)	2023-05-09	2025-10-16	Progentos Therapeutics, Inc.	Heterocyclic compounds and uses thereof
US20250019450A1 (en)	2023-05-19	2025-01-16	Diagonal Therapeutics Inc.	Bispecific agonistic antibodies to il12 receptor
WO2025010272A1 (en)	2023-07-03	2025-01-09	Neoimmunetech, Inc.	Heterodimeric fc molecules and uses thereof
WO2025021942A1 (en)	2023-07-27	2025-01-30	Bracco Suisse Sa	Ultrasound responsive vesicles containing lipid-polyamino acid conjugates
TW202515919A (zh)	2023-09-01	2025-04-16	比利時商艾托斯比利時公司	抗ｔｒｅｍ２抗體及使用方法
WO2025063888A1 (en)	2023-09-19	2025-03-27	Kancure Pte. Ltd.	Survivin-targeted compounds
US20250122182A1 (en)	2023-09-27	2025-04-17	Isosterix, Inc.	MYST Inhibitors
WO2025085416A1 (en)	2023-10-16	2025-04-24	Bristol-Myers Squibb Company	Gspt1 compounds and methods of use of the compounds
US20250179197A1 (en)	2023-10-23	2025-06-05	Diagonal Therapeutics Inc.	Heteromeric agonistic antibodies to il-18 receptor
GB2636969A (en)	2023-11-24	2025-07-09	Ontrack Therapeutics Ltd	Novel crystalline salt forms
WO2025133707A1 (en)	2023-12-19	2025-06-26	Vectory Therapeutics B.V.	Anti-tdp-43 antibodies and uses thereof
WO2025147691A1 (en)	2024-01-04	2025-07-10	Innovo Therapeutics, Inc.	Compositions and methods for degrading aryl hydrocarbon receptor nuclear translocator protein
WO2025179161A1 (en)	2024-02-21	2025-08-28	Innovo Therapeutics, Inc.	Protein degrading compounds
WO2025201633A1 (en)	2024-03-26	2025-10-02	Chen Gefei	An agent for reducing amyloid formation
WO2025255341A1 (en)	2024-06-05	2025-12-11	Protego Biopharma, Inc.	Tetrahydrofuranyl ire1/xbp1s activators
CN118376804B (zh) *	2024-06-25	2024-09-13	华昕生物医药(山东)集团有限公司	脂质体在线提取检测装置

Family Cites Families (239)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3015128A (en) *	1960-08-18	1962-01-02	Southwest Res Inst	Encapsulating apparatus
NL302030A (de)	1962-12-21	1900-01-01
US3291843A (en) *	1963-10-08	1966-12-13	Du Pont	Fluorinated vinyl ethers and their preparation
BE661981A (de) *	1964-04-03
US3594326A (en) *	1964-12-03	1971-07-20	Ncr Co	Method of making microscopic capsules
US3968203A (en) *	1965-10-01	1976-07-06	Jerome G. Spitzer	Aerosol astringent composition
US3488714A (en) *	1966-09-19	1970-01-06	Dow Chemical Co	Formed laminate structure and method of preparation
US3615972A (en) *	1967-04-28	1971-10-26	Dow Chemical Co	Expansible thermoplastic polymer particles containing volatile fluid foaming agent and method of foaming the same
US3532500A (en) *	1967-07-25	1970-10-06	Eastman Kodak Co	Light sensitive vesicular composition comprising an azido-s-triazine compound
US3557294A (en) *	1967-10-12	1971-01-19	Allied Chem	Fluorinated ethers as inhalation convulsants
US3479811A (en) *	1967-11-29	1969-11-25	Dow Chemical Co	Yarn and method of making the same
US3732172A (en) *	1968-02-28	1973-05-08	Ncr Co	Process for making minute capsules and prefabricated system useful therein
US3650831A (en) *	1969-03-10	1972-03-21	Armour Dial Inc	Method of cleaning surfaces
US4027007A (en) *	1970-12-09	1977-05-31	Colgate-Palmolive Company	Antiperspirants formulated with borax
US3873564A (en) *	1971-03-03	1975-03-25	Synvar Ass	2-Imidazolinyl-3-oxide-1-oxypropionic acid
US4108806A (en) *	1971-12-06	1978-08-22	The Dow Chemical Company	Thermoplastic expandable microsphere process and product
US4179546A (en) *	1972-08-28	1979-12-18	The Dow Chemical Company	Method for expanding microspheres and expandable composition
US3960583A (en) *	1974-05-02	1976-06-01	Philadelphia Quartz Company	Method of preparing modified hollow, largely spherical particles by spray drying
CH588887A5 (de) *	1974-07-19	1977-06-15	Battelle Memorial Institute
US3945956A (en) *	1975-06-23	1976-03-23	The Dow Chemical Company	Polymerization of styrene acrylonitrile expandable microspheres
US4138383A (en) *	1975-11-24	1979-02-06	California Institute Of Technology	Preparation of small bio-compatible microspheres
GB1523965A (en) *	1976-03-19	1978-09-06	Ici Ltd	Pharmaceutical compositions containing steroids
US4162282A (en) *	1976-04-22	1979-07-24	Coulter Electronics, Inc.	Method for producing uniform particles
GB1599881A (en) *	1977-02-02	1981-10-07	Millington A R	Preparation for diagnostic radiology
CH624011A5 (de) *	1977-08-05	1981-07-15	Battelle Memorial Institute
CH621479A5 (de) *	1977-08-05	1981-02-13	Battelle Memorial Institute
US4192859A (en) *	1978-09-29	1980-03-11	E. R. Squibb & Sons, Inc.	Contrast media containing liposomes as carriers
US4310506A (en) *	1979-02-22	1982-01-12	California Institute Of Technology	Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
US4276885A (en) *	1979-05-04	1981-07-07	Rasor Associates, Inc	Ultrasonic image enhancement
US4265251A (en) *	1979-06-28	1981-05-05	Rasor Associates, Inc.	Method of determining pressure within liquid containing vessel
US4310505A (en) *	1979-11-08	1982-01-12	California Institute Of Technology	Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4342826A (en) *	1980-02-04	1982-08-03	Collaborative Research, Inc.	Immunoassay products and methods
US4421562A (en) *	1980-04-13	1983-12-20	Pq Corporation	Manufacturing process for hollow microspheres
US4344929A (en) *	1980-04-25	1982-08-17	Alza Corporation	Method of delivering drug with aid of effervescent activity generated in environment of use
US4315514A (en) *	1980-05-08	1982-02-16	William Drewes	Method and apparatus for selective cell destruction
US4331654A (en) *	1980-06-13	1982-05-25	Eli Lilly And Company	Magnetically-localizable, biodegradable lipid microspheres
US4681119A (en) *	1980-11-17	1987-07-21	Schering Aktiengesellschaft	Method of production and use of microbubble precursors
US4657756A (en) *	1980-11-17	1987-04-14	Schering Aktiengesellschaft	Microbubble precursors and apparatus for their production and use
CA1170569A (en)	1980-11-17	1984-07-10	Julia S. Rasor	Microbubble precursors and methods for their production and use
US4442843A (en) *	1980-11-17	1984-04-17	Schering, Ag	Microbubble precursors and methods for their production and use
US4427330A (en) *	1981-03-03	1984-01-24	Carter Charles P	Automatic fence picket stock conveyor for fence picket pointing machine
US4420442A (en) *	1981-04-13	1983-12-13	Pq Corporation	Manufacturing process for hollow microspheres
US4533254A (en) *	1981-04-17	1985-08-06	Biotechnology Development Corporation	Apparatus for forming emulsions
EP0068961A3 (de) *	1981-06-26	1983-02-02	Thomson-Csf	Vorrichtung zur lokalen Erwärmung von biologischen Gewebe
US4426330A (en) *	1981-07-20	1984-01-17	Lipid Specialties, Inc.	Synthetic phospholipid compounds
US4534899A (en) *	1981-07-20	1985-08-13	Lipid Specialties, Inc.	Synthetic phospholipid compounds
US4569836A (en) *	1981-08-27	1986-02-11	Gordon Robert T	Cancer treatment by intracellular hyperthermia
DE3141641A1 (de) *	1981-10-16	1983-04-28	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Ultraschall-kontrastmittel und dessen herstellung
BR8107560A (pt) *	1981-11-19	1983-07-05	Luiz Romariz Duarte	Estimulacao ultra-sonica da consolidacao de fraturas osseas
US4540629A (en) *	1982-04-08	1985-09-10	Pq Corporation	Hollow microspheres with organosilicon-silicate walls
DE3225848A1 (de) *	1982-07-07	1984-01-19	Schering AG, 1000 Berlin und 4709 Bergkamen	Kortikoidhaltige zubereitung zur topischen applikation
US4549892A (en) *	1982-09-22	1985-10-29	Baker Alfred G	Process for producing hollow, bilayered silicate microspheres
FR2534487B1 (fr)	1982-10-15	1988-06-10	Dior Christian Parfums	Procede d'homogeneisation de dispersions de phases lamellaires lipidiques hydratees, et suspensions obtenues par ce procede
EP0111386B1 (de) *	1982-10-26	1987-11-19	University Of Aberdeen	Ultraschallanlage zur Hyperthermie
US4603044A (en) *	1983-01-06	1986-07-29	Technology Unlimited, Inc.	Hepatocyte Directed Vesicle delivery system
US4731239A (en) *	1983-01-10	1988-03-15	Gordon Robert T	Method for enhancing NMR imaging; and diagnostic use
US4572203A (en) *	1983-01-27	1986-02-25	Feinstein Steven B	Contact agents for ultrasonic imaging
US4718433A (en) *	1983-01-27	1988-01-12	Feinstein Steven B	Contrast agents for ultrasonic imaging
US4775522A (en) *	1983-03-04	1988-10-04	Children's Hospital Research Foundation, A Division Of Children's Hospital Medical Center	NMR compositions for indirectly detecting a dissolved gas in an animal
US4981692A (en) *	1983-03-24	1991-01-01	The Liposome Company, Inc.	Therapeutic treatment by intramammary infusion
US5141738A (en) *	1983-04-15	1992-08-25	Schering Aktiengesellschaft	Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof
US4485193A (en)	1983-05-10	1984-11-27	The Dow Chemical Company	Expandable synthetic resinous thermoplastic particles, method for the preparation thereof and the application therefor
US4544545A (en) *	1983-06-20	1985-10-01	Trustees University Of Massachusetts	Liposomes containing modified cholesterol for organ targeting
US4900540A (en) *	1983-06-20	1990-02-13	Trustees Of The University Of Massachusetts	Lipisomes containing gas for ultrasound detection
US4615879A (en) *	1983-11-14	1986-10-07	Vanderbilt University	Particulate NMR contrast agents for gastrointestinal application
FR2563725B1 (fr) *	1984-05-03	1988-07-15	Dory Jacques	Appareil d'examen et de localisation de tumeurs par ultrasons muni d'un dispositif de traitement localise par hyperthermie
DE3585967D1 (de) *	1984-03-08	1992-06-11	Phares Pharma Holland	Liposombildende zusammensetzung.
GB8407557D0 (en) *	1984-03-23	1984-05-02	Hayward J A	Polymeric lipsomes
US4728575A (en) *	1984-04-27	1988-03-01	Vestar, Inc.	Contrast agents for NMR imaging
US5008109A (en) *	1984-05-25	1991-04-16	Vestar, Inc.	Vesicle stabilization
US5008050A (en) *	1984-06-20	1991-04-16	The Liposome Company, Inc.	Extrusion technique for producing unilamellar vesicles
US4620546A (en) *	1984-06-30	1986-11-04	Kabushiki Kaisha Toshiba	Ultrasound hyperthermia apparatus
SE8403905D0 (sv) *	1984-07-30	1984-07-30	Draco Ab	Liposomes and steroid esters
US4789501A (en) *	1984-11-19	1988-12-06	The Curators Of The University Of Missouri	Glass microspheres
US4921706A (en) *	1984-11-20	1990-05-01	Massachusetts Institute Of Technology	Unilamellar lipid vesicles and method for their formation
US4830858A (en) *	1985-02-11	1989-05-16	E. R. Squibb & Sons, Inc.	Spray-drying method for preparing liposomes and products produced thereby
US4689986A (en) *	1985-03-13	1987-09-01	The University Of Michigan	Variable frequency gas-bubble-manipulating apparatus and method
US5186922A (en) *	1985-03-15	1993-02-16	See/Shell Biotechnology, Inc.	Use of biodegradable microspheres labeled with imaging energy constrast materials
US4663161A (en) *	1985-04-22	1987-05-05	Mannino Raphael J	Liposome methods and compositions
AU587472B2 (en) *	1985-05-22	1989-08-17	Liposome Technology, Inc.	Liposome inhalation method and system
EP0216730B1 (de)	1985-08-12	1991-01-23	Battelle Memorial Institute	Poröse Filtrierungsglaskugeln und Methode zu deren Herstellung
US4684479A (en) *	1985-08-14	1987-08-04	Arrigo Joseph S D	Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
US4938947A (en) *	1985-11-01	1990-07-03	Centre National De La Recherche Scientifique (Cnrs)	Aerosol composition for in vivo imaging
US4865836A (en) *	1986-01-14	1989-09-12	Fluoromed Pharmaceutical, Inc.	Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4987154A (en) *	1986-01-14	1991-01-22	Alliance Pharmaceutical Corp.	Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US4927623A (en) *	1986-01-14	1990-05-22	Alliance Pharmaceutical Corp.	Dissolution of gas in a fluorocarbon liquid
DE3785054T2 (de)	1986-01-24	1993-07-08	Childrens Hosp Medical Center	Stabile emulsionen von stark fluorierten, organischen verbindungen.
US4737323A (en) *	1986-02-13	1988-04-12	Liposome Technology, Inc.	Liposome extrusion method
US4834964A (en) *	1986-03-07	1989-05-30	M.R.I., Inc.	Use of charged nitroxides as NMR image enhancing agents for CSF
JPH0751496B2 (ja) *	1986-04-02	1995-06-05	武田薬品工業株式会社	リポソ−ムの製造法
DE3614657A1 (de)	1986-04-30	1987-11-05	Dornier Medizintechnik	Pharmaka enthaltende lipidvesikel, verfahren zu ihrer herstellung und einbringung in den koerper eines lebewesens und freisetzung der in den lipidvesikeln enthaltende pharmaka
FR2602774B1 (fr) *	1986-07-29	1990-10-19	Atta	Nouvelles molecules amphiphiles polyhydroxylees et perfluoroalkylees ayant des proprietes tensioactives
IL79559A0 (en)	1986-07-29	1986-10-31	Univ Ramot	Contrast agents for nmr medical imaging
US4728578A (en) *	1986-08-13	1988-03-01	The Lubrizol Corporation	Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing polymers
US4776991A (en) *	1986-08-29	1988-10-11	The United States Of America As Represented By The Secretary Of The Navy	Scaled-up production of liposome-encapsulated hemoglobin
JPS6360943A (ja) *	1986-09-01	1988-03-17	Green Cross Corp:The	超音波診断造影剤
US4781871A (en) *	1986-09-18	1988-11-01	Liposome Technology, Inc.	High-concentration liposome processing method
US4769241A (en) *	1986-09-23	1988-09-06	Alpha Therapeutic Corporation	Apparatus and process for oxygenation of liquid state dissolved oxygen-carrying formulation
ZW11287A1 (en) *	1986-11-04	1989-01-25	Aeci Ltd	Process for the production of an explosive
DE3637926C1 (de) *	1986-11-05	1987-11-26	Schering Ag	Ultraschall-Manometrieverfahren in einer Fluessigkeit mittels Mikroblaeschen
US5049388A (en) *	1986-11-06	1991-09-17	Research Development Foundation	Small particle aerosol liposome and liposome-drug combinations for medical use
US4863717A (en) *	1986-11-10	1989-09-05	The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon	Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging
JPH0722311B2 (ja) *	1986-11-13	1995-03-08	キヤノン株式会社	カラ−画像読み取り装置
US4933121A (en) *	1986-12-10	1990-06-12	Ciba Corning Diagnostics Corp.	Process for forming liposomes
DK175531B1 (da)	1986-12-15	2004-11-22	Nexstar Pharmaceuticals Inc	Leveringsvehikel med amphiphil-associeret aktiv bestanddel
CA1321048C (en) *	1987-03-05	1993-08-10	Robert W. J. Lencki	Microspheres and method of producing same
US5219538A (en) *	1987-03-13	1993-06-15	Micro-Pak, Inc.	Gas and oxygen carrying lipid vesicles
US5000960A (en) *	1987-03-13	1991-03-19	Micro-Pak, Inc.	Protein coupling to lipid vesicles
CH672733A5 (de)	1987-05-22	1989-12-29	Bracco Ind Chimica Spa
JP2690987B2 (ja) *	1987-06-23	1997-12-17	ハフスルンド・ニユコメド・イノベイション・アクチェボラーグ	磁気共鳴像形成における改良
US5354549A (en)	1987-07-24	1994-10-11	Nycomed Imaging As	Iodinated esters
DE3741201A1 (de)	1987-12-02	1989-06-15	Schering Ag	Ultraschallarbeitsverfahren und mittel zu dessen durchfuehrung
US4844882A (en) *	1987-12-29	1989-07-04	Molecular Biosystems, Inc.	Concentrated stabilized microbubble-type ultrasonic imaging agent
IE61591B1 (en)	1987-12-29	1994-11-16	Molecular Biosystems Inc	Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
US5425366A (en) *	1988-02-05	1995-06-20	Schering Aktiengesellschaft	Ultrasonic contrast agents for color Doppler imaging
EP0327490A1 (de)	1988-02-05	1989-08-09	Schering Aktiengesellschaft	Ultraschallkontrastmittel, Verfahren zu deren Herstellung und deren Verwendung als Diagnostika und Therapeutika
DE3803972A1 (de)	1988-02-05	1989-08-10	Schering Ag	Ultraschallkontrastmittel
US4898734A (en) *	1988-02-29	1990-02-06	Massachusetts Institute Of Technology	Polymer composite for controlled release or membrane formation
DE3812816A1 (de)	1988-04-16	1989-11-02	Lawaczeck Ruediger Dipl Phys P	Verfahren zur solubilisierung von liposomen und/oder biologischer membranen sowie deren verwendung
US5171755A (en) *	1988-04-29	1992-12-15	Hemagen/Pfc	Emulsions of highly fluorinated organic compounds
US5422120A (en)	1988-05-30	1995-06-06	Depotech Corporation	Heterovesicular liposomes
US4893624A (en) *	1988-06-21	1990-01-16	Massachusetts Institute Of Technology	Diffuse focus ultrasound hyperthermia system
DE3824354A1 (de)	1988-07-19	1990-01-25	Basf Ag, 67063 Ludwigshafen	Verfahren zur herstellung von zellhaltigen kunststoffen nach dem polyisocyanat-polyadditionsverfahren mittels lagerstabiler, treibmittelhaltiger emulsionen und diese emulsionen
US4996041A (en) *	1988-08-19	1991-02-26	Toshiyuki Arai	Method for introducing oxygen-17 into tissue for imaging in a magnetic resonance imaging system
US4993415A (en) *	1988-08-19	1991-02-19	Alliance Pharmaceutical Corp.	Magnetic resonance imaging with perfluorocarbon hydrides
DE3828905A1 (de)	1988-08-23	1990-03-15	Schering Ag	Mittel bestehend aus cavitate oder clathrate bildenden wirt/gast-komplexen als kontrastmittel
US5045304A (en) *	1988-08-31	1991-09-03	Wayne State University	Contras agent having an imaging agent coupled to viable granulocytes for use in magnetic resonance imaging of abscess and a method of preparing and using same
US5410516A (en) *	1988-09-01	1995-04-25	Schering Aktiengesellschaft	Ultrasonic processes and circuits for performing them
DE3829999A1 (de)	1988-09-01	1990-03-15	Schering Ag	Ultraschallverfahren und schaltungen zu deren durchfuehrung
US4957656A (en) *	1988-09-14	1990-09-18	Molecular Biosystems, Inc.	Continuous sonication method for preparing protein encapsulated microbubbles
IL91664A (en) *	1988-09-28	1993-05-13	Yissum Res Dev Co	Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
FR2637182B1 (fr) *	1988-10-03	1992-11-06	Lvmh Rech	Compositions a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un ecdysteroide, de preference l'ecdysterone, ou l'un de ses derives; et compositions cosmetiques, pharmaceutiques, notamment dermatologiques, de sericulture ou phytosanitaires l'incorporant
US5114703A (en) *	1989-05-30	1992-05-19	Alliance Pharmaceutical Corp.	Percutaneous lymphography using particulate fluorocarbon emulsions
DE69002767T2 (de)	1989-06-22	1994-03-17	Atta	Fluor- und phosphorhaltige amphiphilische moleküle mit oberflächenaktiven eigenschaften.
US5019370A (en) *	1989-07-10	1991-05-28	University Of Kentucky Research Foundation	Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging
US5194266A (en) *	1989-08-08	1993-03-16	Liposome Technology, Inc.	Amphotericin B/cholesterol sulfate composition and method
US5562608A (en)	1989-08-28	1996-10-08	Biopulmonics, Inc.	Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5013556A (en) *	1989-10-20	1991-05-07	Liposome Technology, Inc.	Liposomes with enhanced circulation time
US5620689A (en)	1989-10-20	1997-04-15	Sequus Pharmaceuuticals, Inc.	Liposomes for treatment of B-cell and T-cell disorders
US5352435A (en) *	1989-12-22	1994-10-04	Unger Evan C	Ionophore containing liposomes for ultrasound imaging
US5469854A (en)	1989-12-22	1995-11-28	Imarx Pharmaceutical Corp.	Methods of preparing gas-filled liposomes
US5305757A (en) *	1989-12-22	1994-04-26	Unger Evan C	Gas filled liposomes and their use as ultrasonic contrast agents
US5088499A (en) *	1989-12-22	1992-02-18	Unger Evan C	Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5585112A (en) *	1989-12-22	1996-12-17	Imarx Pharmaceutical Corp.	Method of preparing gas and gaseous precursor-filled microspheres
US5123414A (en) *	1989-12-22	1992-06-23	Unger Evan C	Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5230882A (en) *	1989-12-22	1993-07-27	Unger Evan C	Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5149319A (en) *	1990-09-11	1992-09-22	Unger Evan C	Methods for providing localized therapeutic heat to biological tissues and fluids
US5542935A (en)	1989-12-22	1996-08-06	Imarx Pharmaceutical Corp.	Therapeutic delivery systems related applications
US5580575A (en)	1989-12-22	1996-12-03	Imarx Pharmaceutical Corp.	Therapeutic drug delivery systems
US5334381A (en) *	1989-12-22	1994-08-02	Unger Evan C	Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5209720A (en) *	1989-12-22	1993-05-11	Unger Evan C	Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
US5228446A (en) *	1989-12-22	1993-07-20	Unger Evan C	Gas filled liposomes and their use as ultrasonic contrast agents
DE4004430A1 (de)	1990-02-09	1991-08-14	Schering Ag	Aus polyaldehyden aufgebaute kontrastmittel
US5445813A (en)	1992-11-02	1995-08-29	Bracco International B.V.	Stable microbubble suspensions as enhancement agents for ultrasound echography
US5556610A (en)	1992-01-24	1996-09-17	Bracco Research S.A.	Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method
IN172208B (de) *	1990-04-02	1993-05-01	Sint Sa
US5578292A (en)	1991-11-20	1996-11-26	Bracco International B.V.	Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US5672585A (en)	1990-04-06	1997-09-30	La Jolla Cancer Research Foundation	Method and composition for treating thrombosis
US5358702A (en)	1990-04-10	1994-10-25	Unger Evan C	Methoxylated gel particle contrast media for improved diagnostic imaging
US5078994A (en) *	1990-04-12	1992-01-07	Eastman Kodak Company	Microgel drug delivery system
JPH03297475A (ja)	1990-04-16	1991-12-27	Ken Ishihara	共振音波により薬物の放出を制御する方法
US5288446A (en) *	1990-04-23	1994-02-22	Sumitomo Rubber Industries, Ltd.	Production of rubber article
US5190982A (en) *	1990-04-26	1993-03-02	Hoechst Aktiengesellschaft	Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5137928A (en) *	1990-04-26	1992-08-11	Hoechst Aktiengesellschaft	Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5205287A (en) *	1990-04-26	1993-04-27	Hoechst Aktiengesellschaft	Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
AU636481B2 (en)	1990-05-18	1993-04-29	Bracco International B.V.	Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
US5196348A (en)	1990-06-11	1993-03-23	Air Products And Chemicals, Inc.	Perfluoro-crown ethers in fluorine magnetic resonance spectroscopy of biopsied tissue
US5315997A (en)	1990-06-19	1994-05-31	Molecular Biosystems, Inc.	Method of magnetic resonance imaging using diamagnetic contrast
US5215680A (en)	1990-07-10	1993-06-01	Cavitation-Control Technology, Inc.	Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
IL95743A (en)	1990-09-19	1993-02-21	Univ Ramot	Method of measuring blood flow
US5487390A (en)	1990-10-05	1996-01-30	Massachusetts Institute Of Technology	Gas-filled polymeric microbubbles for ultrasound imaging
DE69110656T2 (de) *	1990-10-05	1995-11-09	Bracco Int Bv	Verfahren zur herstellung von stabilen suspensionen von hohlen mit gasgefüllten mikrosphären zur verwendung in ultraschallechographie.
AU657111B2 (en)	1990-12-20	1995-03-02	Dana-Farber Cancer Institute	Control of gene expression by ionizing radiation
US5107842A (en)	1991-02-22	1992-04-28	Molecular Biosystems, Inc.	Method of ultrasound imaging of the gastrointestinal tract
US5144703A (en) *	1991-03-04	1992-09-08	Maire Laura M	Bathtub liner
EP0732106A3 (de)	1991-03-22	2003-04-09	Katsuro Tachibana	Mikrobläschen enthaltende Verstärker zur Ultraschalltherapie von Erkrankungen
GB9106673D0 (en)	1991-03-28	1991-05-15	Hafslund Nycomed As	Improvements in or relating to contrast agents
GB9106686D0 (en)	1991-03-28	1991-05-15	Hafslund Nycomed As	Improvements in or relating to contrast agents
US5874062A (en)	1991-04-05	1999-02-23	Imarx Pharmaceutical Corp.	Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5205290A (en)	1991-04-05	1993-04-27	Unger Evan C	Low density microspheres and their use as contrast agents for computed tomography
US5496535A (en)	1991-04-12	1996-03-05	Alliance Pharmaceutical Corp.	Fluorocarbon contrast media for use with MRI and radiographic imaging
US5147631A (en) *	1991-04-30	1992-09-15	Du Pont Merck Pharmaceutical Company	Porous inorganic ultrasound contrast agents
HK1006946A1 (en)	1991-06-03	1999-03-26	Nycomed Imaging As	Improvements in or relating to contrast agents
WO1992022298A1 (en) *	1991-06-18	1992-12-23	Unger Evan C	Novel liposomal drug delivery systems
GB9116610D0 (en)	1991-08-01	1991-09-18	Danbiosyst Uk	Preparation of microparticles
JP3231768B2 (ja)	1991-09-17	2001-11-26	ソーナスファーマシューティカルス，インコーポレイテッド	気体状超音波造影剤及び超音波造影剤として使用する気体の選定方法
MX9205298A (es)	1991-09-17	1993-05-01	Steven Carl Quay	Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US5409688A (en)	1991-09-17	1995-04-25	Sonus Pharmaceuticals, Inc.	Gaseous ultrasound contrast media
US5362477A (en)	1991-10-25	1994-11-08	Mallinckrodt Medical, Inc.	19F magnetic resonance imaging agents which include a nitroxide moiety
US5196183A (en) *	1991-12-04	1993-03-23	Sterling Winthrop Inc.	Contrast agents for ultrasound imaging
GB9200387D0 (en)	1992-01-09	1992-02-26	Nycomed As	Improvements in or relating to contrast agents
GB9200388D0 (en)	1992-01-09	1992-02-26	Nycomed As	Improvements in or relating to contrast agents
IL104084A (en)	1992-01-24	1996-09-12	Bracco Int Bv	Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
US5470582A (en)	1992-02-07	1995-11-28	Syntex (U.S.A.) Inc.	Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
JP3325300B2 (ja)	1992-02-28	2002-09-17	株式会社東芝	超音波治療装置
US5247935A (en)	1992-03-19	1993-09-28	General Electric Company	Magnetic resonance guided focussed ultrasound surgery
US5858399A (en)	1992-04-09	1999-01-12	Northwestern University	Acoustically reflective liposomes and methods to make and use the same
WO1993020802A1 (en)	1992-04-09	1993-10-28	Northwestern University	Acoustically reflective liposomes and methods to make and use the same
US5339814A (en)	1992-04-14	1994-08-23	Lasker Sigmund E	Process for visualizing tissue metabolism using oxygen-17
US5846516A (en)	1992-06-03	1998-12-08	Alliance Pharmaceutial Corp.	Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
DE4221256C2 (de)	1992-06-26	1997-07-10	Lancaster Group Ag	Galenische Zusammensetzung für die topische Anwendung
US5552155A (en)	1992-12-04	1996-09-03	The Liposome Company, Inc.	Fusogenic lipsomes and methods for making and using same
US5558855A (en)	1993-01-25	1996-09-24	Sonus Pharmaceuticals	Phase shift colloids as ultrasound contrast agents
CN1068230C (zh)	1993-01-25	2001-07-11	索纳斯药品有限公司	用作超声造影剂的相转变胶体
FR2700952B1 (fr)	1993-01-29	1995-03-17	Oreal	Nouvelles compositions cosmétiques ou dermopharmaceutiques sous forme de gels aqueux modifiés par addition de microsphères expansées.
US5362478A (en)	1993-03-26	1994-11-08	Vivorx Pharmaceuticals, Inc.	Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
NZ262679A (en)	1993-02-22	1997-08-22	Vivorx Pharmaceuticals Inc	Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
WO1994021303A1 (en)	1993-03-16	1994-09-29	Alliance Pharmaceutical Corp.	Fluorocarbon compositions containing a visible or fluorescent label
US5567415A (en)	1993-05-12	1996-10-22	The Board Of Regents Of The University Of Nebraska	Ultrasound contrast agents and methods for their manufacture and use
US5701899A (en)	1993-05-12	1997-12-30	The Board Of Regents Of The University Of Nebraska	Perfluorobutane ultrasound contrast agent and methods for its manufacture and use
US5716597A (en)	1993-06-04	1998-02-10	Molecular Biosystems, Inc.	Emulsions as contrast agents and method of use
NZ268826A (en)	1993-07-02	1996-11-26	Molecular Biosystems Inc	Protein encapsulated gas microspheres and their use in ultrasonic imaging
US5855865A (en)	1993-07-02	1999-01-05	Molecular Biosystems, Inc.	Method for making encapsulated gas microspheres from heat denatured protein in the absence of oxygen gas
US5565215A (en)	1993-07-23	1996-10-15	Massachusettes Institute Of Technology	Biodegradable injectable particles for imaging
DK0711179T3 (da)	1993-07-30	2005-02-14	Imcor Pharmaceutical Co	Stabiliserede sammensætninger med mikrobobler til ultralyd
US5433204A (en) *	1993-11-16	1995-07-18	Camilla Olson	Method of assessing placentation
CA2185810A1 (en)	1994-03-28	1995-10-05	Jo Klaveness	Liposomes
US5545396A (en)	1994-04-08	1996-08-13	The Research Foundation Of State University Of New York	Magnetic resonance imaging using hyperpolarized noble gases
WO1995029705A1 (en)	1994-05-03	1995-11-09	Molecular Biosystems, Inc.	Composition for ultrasonically quantitating myocardial perfusion
US5571797A (en)	1994-05-11	1996-11-05	Arch Development Corporation	Method of inducing gene expression by ionizing radiation
US5502094A (en)	1994-05-20	1996-03-26	Minnesota Mining And Manufacturing Company	Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
US5736121A (en)	1994-05-23	1998-04-07	Imarx Pharmaceutical Corp.	Stabilized homogenous suspensions as computed tomography contrast agents
US5562893A (en)	1994-08-02	1996-10-08	Molecular Biosystems, Inc.	Gas-filled microspheres with fluorine-containing shells
US5509896A (en)	1994-09-09	1996-04-23	Coraje, Inc.	Enhancement of thrombolysis with external ultrasound
US5540909A (en)	1994-09-28	1996-07-30	Alliance Pharmaceutical Corp.	Harmonic ultrasound imaging with microbubbles
US5569448A (en)	1995-01-24	1996-10-29	Nano Systems L.L.C.	Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
EP0727225A3 (de)	1995-02-14	1997-01-15	Sonus Pharma Inc	Zusammensetzungen und Verfahren zur Herstellung von gerichteter Ultraschallabbildung
US5556372A (en)	1995-02-15	1996-09-17	Exogen, Inc.	Apparatus for ultrasonic bone treatment
US5560364A (en)	1995-05-12	1996-10-01	The Board Of Regents Of The University Of Nebraska	Suspended ultra-sound induced microbubble cavitation imaging
US5558092A (en)	1995-06-06	1996-09-24	Imarx Pharmaceutical Corp.	Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
US5606973A (en)	1995-06-07	1997-03-04	Molecular Biosystems, Inc.	Liquid core microdroplets for ultrasound imaging
US5897851A (en)	1995-06-07	1999-04-27	Sonus Pharmaceuticals, Inc.	Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
US5804162A (en)	1995-06-07	1998-09-08	Alliance Pharmaceutical Corp.	Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US5648098A (en)	1995-10-17	1997-07-15	The Board Of Regents Of The University Of Nebraska	Thrombolytic agents and methods of treatment for thrombosis
US5840023A (en)	1996-01-31	1998-11-24	Oraevsky; Alexander A.	Optoacoustic imaging for medical diagnosis
US5976501A (en)	1996-06-07	1999-11-02	Molecular Biosystems, Inc.	Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion
US5849727A (en)	1996-06-28	1998-12-15	Board Of Regents Of The University Of Nebraska	Compositions and methods for altering the biodistribution of biological agents
US5846517A (en)	1996-09-11	1998-12-08	Imarx Pharmaceutical Corp.	Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6548047B1 (en)	1997-09-15	2003-04-15	Bristol-Myers Squibb Medical Imaging, Inc.	Thermal preactivation of gaseous precursor filled compositions

1993
- 1993-11-30 US US08/159,687 patent/US5585112A/en not_active Expired - Lifetime
1994
- 1994-05-20 DK DK94919208T patent/DK0712293T3/da active
- 1994-05-20 WO PCT/US1994/005792 patent/WO1994028780A2/en not_active Ceased
- 1994-05-20 DE DE122007000024C patent/DE122007000024I2/de active Active
- 1994-05-20 EP EP02078168A patent/EP1252885A3/de not_active Withdrawn
- 1994-05-20 AT AT94919208T patent/ATE233574T1/de active
- 1994-05-20 CA CA002164845A patent/CA2164845C/en not_active Expired - Lifetime
- 1994-05-20 AU AU70431/94A patent/AU683900B2/en not_active Ceased
- 1994-05-20 DE DE69432219T patent/DE69432219T2/de not_active Expired - Lifetime
- 1994-05-20 EP EP94919208A patent/EP0712293B1/de not_active Expired - Lifetime
- 1994-05-20 ES ES94919208T patent/ES2193161T3/es not_active Expired - Lifetime
- 1994-05-20 PT PT94919208T patent/PT712293E/pt unknown
- 1994-05-20 CN CN94192402A patent/CN1125654C/zh not_active Expired - Lifetime
- 1994-05-20 JP JP50183995A patent/JP4274387B2/ja not_active Expired - Lifetime
1995
- 1995-06-06 US US08/487,230 patent/US5853752A/en not_active Expired - Lifetime
1997
- 1997-10-02 US US08/942,862 patent/US6071495A/en not_active Expired - Fee Related
1998
- 1998-07-17 US US09/118,329 patent/US6479034B1/en not_active Expired - Fee Related
2007
- 2007-03-13 NL NL300267C patent/NL300267I2/nl unknown
- 2007-03-16 LU LU91325C patent/LU91325I2/fr unknown
- 2007-07-23 JP JP2007190697A patent/JP4916969B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2193161T3 (es)	2003-11-01
US6071495A (en)	2000-06-06
CA2164845A1 (en)	1994-12-22
PT712293E (pt)	2003-07-31
CN1125389A (zh)	1996-06-26
DE69432219D1 (de)	2003-04-10
EP0712293A1 (de)	1996-05-22
JP2007314559A (ja)	2007-12-06
AU683900B2 (en)	1997-11-27
NL300267I2 (nl)	2007-10-01
US5585112A (en)	1996-12-17
ATE233574T1 (de)	2003-03-15
US5853752A (en)	1998-12-29
JP4916969B2 (ja)	2012-04-18
AU7043194A (en)	1995-01-03
CN1125654C (zh)	2003-10-29
WO1994028780A2 (en)	1994-12-22
EP1252885A2 (de)	2002-10-30
EP1252885A3 (de)	2003-04-16
LU91325I2 (fr)	2007-05-16
DK0712293T3 (da)	2003-06-30
EP0712293A4 (de)	1998-05-06
NL300267I1 (nl)	2007-05-01
DE122007000024I2 (de)	2011-06-16
US6479034B1 (en)	2002-11-12
JP4274387B2 (ja)	2009-06-03
DE69432219T2 (de)	2003-12-04
EP0712293B1 (de)	2003-03-05
JPH08511526A (ja)	1996-12-03
CA2164845C (en)	2008-04-29
WO1994028780A3 (en)	1995-02-02

Publication	Publication Date	Title
DE122007000024I1 (de)	2007-10-04	Verfahren zur Herstellung von gasgef}llten Lipid-mikropartikeln und gasgef}llte Lipid-mikroartikel
DE69431753D1 (de)	2003-01-02	Verfahren zur bereitung von liposomen mit gaseinschlüssen
DE69333607D1 (de)	2004-09-30	Vorrichtung zur Herstellung von vorgefüllten, sterilen Abgabevorrichtungen
NO20002788D0 (no)	2000-05-31	Nye forbindelser
HUT65846A (en)	1994-07-28	Method for preparation of o-glycosylated alpha-interferons and medicinal drugs containing it
DE68910969D1 (de)	1994-01-05	Verfahren und vorrichtung zur herstellung von lipidbläschen.
DE69617088D1 (de)	2002-01-03	Verfahren zur Herstellung von kristallisiertem Maltit und diesen enthaltenden Kristallinen.
ATE165749T1 (de)	1998-05-15	Mehrkomponentemulsionen und verfahren zur deren herstellung
DE69007714D1 (de)	1994-05-05	Pharmazeutische Zubereitung mit antitumoraler Wirkung und Verfahren zur Herstellung.
SE8800080L (sv)	1989-07-14	Laekemedelskomposition
DE59500727D1 (de)	1997-11-06	Vorrichtung zur Herstellung von Aufgussgetränken
DE69823275T2 (de)	2005-04-21	Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Arzneimitteln
IT1178231B (it)	1987-09-09	Apparecchio e procedimento per accogliere gruppi ordinati di contenitori per ulteriore trattamento, ad esempio la sterilizzazione di contenitori di prodotti farmaceutici
DE59300883D1 (de)	1995-12-14	Verfahren zur Herstellung von Dianthrachinon-N,N'-dihydroazin und dessen Chlorierungsprodukten.
DE59505070D1 (de)	1999-03-25	Verfahren zur Herstellung von aliphatischen und cycloaliphatischen Oximen
SE9002274D0 (sv)	1990-06-28	Novel 3,3'-dithiobis(propionic esters).
DE59202769D1 (de)	1995-08-10	Verfahren zur Herstellung von 3-Alkoxycarbonylpropenalen und 3-Dialkoxymethylpropenalen.
TH17541A (th)	1996-01-23	สารประกอบเฮเทอโรไซคลิค
ATE105183T1 (de)	1994-05-15	Mittel zur arzneistoffabgabe und verfahren zu deren herstellung.